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Abstract 
Lower limb lymphoedema (LLL) following surgery for stage III metastatic melanoma (MM) 
of the groin/pelvis is a common occurrence and can impact on all domains of occupational 
performance. Gaps in literature exist regarding the experiences, impacts and needs of 
people with stage III MM who require groin/pelvic node dissection.  Additionally, the impact 
of monitoring, preventative approaches or treatment for lymphoedema on occupational 
performance is unknown. Occupational therapists working in this area must have specialist 
knowledge and understanding of both melanoma and lymphoedema to facilitate 
appropriate, evidence-based care within an occupational therapy model of care. 
This study aimed to explore the experiences, needs and occupational performance 
impacts of people who are at risk, or have developed LLL following inguinal (groin) or ilio-
inguinal (groin/pelvic) node dissection for stage III metastatic melanoma. The research 
questions were:  
1. What are the experiences, impacts and needs of people with stage III MM following 
surgery to the groin/pelvis? 
2. What are people’s perceptions of monitoring and proactive, preventative approaches to 
LLL following surgery for stage III MM?  
Using an interpretive descriptive (ID) methodology, twenty interviews were conducted with 
a purposive sample of eleven people from a major tertiary hospital in Australia. Interviews 
were conducted between 8-18 months following surgery, recorded and transcribed 
verbatim. Data were analysed using ID methods to inductively generate themes.  Of the 
eleven participants being prospectively monitored, (5=male; 6=female), six developed LLL 
(2=male; 4=female). This was a very difficult time that had significant impact on 
participants’ lives. Five themes were inductively generated from the data and included: 1) 
reactions to metastatic melanoma; 2) the possibility of lymphoedema; 3) impacts on 
occupation, personal relationships and identity; 4) professional relationships; and 5) from 
crisis to coping and reframing. 
Understanding the experiences, impacts and needs of this group and how stage III MM of 
the groin/pelvis, subsequent surgery, monitoring and/or preventative treatments for LLL 
impact on occupational performance, can inform the planning and delivery of specialist 
occupational therapy services for these people. The results of this study suggest that 
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there are benefits from inter-professional team follow-up and that more attention could be 
paid to the impacts of MM and LLL on a person’s occupational performance.   Prospective 
monitoring for LLL was well received by people who had undergone ilioinguinal node 
dissection for stage III MM and it is recommended that prospective monitoring for LLL be 
considered by lymphoedema trained occupational therapists in conjunction with standard 
surgical follow-up treatments that routinely exist in current models of care. Increased 
monitoring and support throughout the journey of adjustment with MM would ensure early 
detection, facilitate ongoing education of LLL and skill acquisition to maximise self-efficacy 
in self-care for either risk reduction or management of the condition should LLL occur.  
Occupational performance and occupational roles following stage III MM and LLL are 
affected and the implications on identity should also be considered during care. The 
experience of being involved in a proactive, preventative program was reported as 
positive and whilst formal quantitative outcomes are not reported in this thesis, reports in 
this study were that the prophylactic wearing of compression garments and conducting 
lymphatic drainage for 6-months following surgery was not considered a burden for those 
involved.  It provided people with a choice and a feeling of control, which they perceived 
assisted their recovery.  
Findings from this study indicated that a collaborative approach is necessary to support 
people with MM and LLL throughout the continuum of care. Occupational therapists are 
well placed to assess, manage and guide a person through the physical and psychosocial 
sequelae that may negatively impact occupational performance. Clinical implications and 
recommendations are made in this thesis to assist in providing care to people who are at 
high risk of LLL following surgery for stage III MM of the groin/pelvis.    
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CHAPTER 1: INTRODUCTION 
1.1 OVERVIEW OF THE THESIS TOPIC 
Lower limb lymphoedema (LLL) following surgery for stage III malignant melanoma (MM) 
of the groin (inguinal) or groin/pelvis (ilio-inguinal)  is a common occurrence (Allan, 
Hayes, & Thomas, 2008; Glover et al., 2014; Spillane et al., 2011; Theodore et al., 2017). 
The documented prevalence of LLL  following inguinal (groin) or ilio-inguinal (groin/pelvic) 
node dissection for stage III MM ranges from 6% to 66% (Abbas & Seitz, 2011; Allan et 
al., 2008; de Vries, Hoekstra, & Hoekstra-Weebers, 2009; Faries et al., 2010; Poos et al., 
2009; Sarnaik, Puleo, Zager, & Sondak, 2009; Serpell, Carne, & Bailey, 2003; Sondak & 
Sarnaik, 2011; Spillane et al., 2008). Such wide ranges in reporting variables are due to 
inconsistent definitions, a lack of consensus regarding a definitive definition of LLL, 
variability in methods of measurement and differences in reporting retrospectively or 
prospectively.  
 
The treatment, monitoring or prevention of LLL following groin/pelvic node dissection often 
falls within the role of the lymphoedema trained occupational therapist.  Throughout the 
process of restoring function and minimising disability, a therapist will aim to return a 
person to their highest level of independence  therefore, empowering people to return to 
participation in valued occupations and roles. Occupational therapists who are trained as 
lymphoedema therapists have a specialised role in assessing and treating lymphoedema 
including the associated symptoms and impacts, whilst addressing issues that arise 
regarding occupational performance.  Christiansen, Baum, and Bass (2015, p 52) define 
occupational performance as “the doing of meaningful activities, tasks and roles through 
complex interactions between the person and environment” and it is a basic premise of 
occupational therapy that occupational performance influences a person’s health and well-
being (AOTA., 2002; Chapparo & Ranka, 1997; Christiansen, Baum, & Bass, 2015; 
Kielhofner, 2008; Law, Baum, & Dunn, 2005). This is congruent with the approach to 
alleviate physical symptoms associated with lymphoedema, minimise infection risk, and 
improve function and quality of life outlined in the International Lymphoedema Framework 
(2006).   
Melanoma prevalence has increased more than all major cancers in the past 40 years 
(Diffey, 2004).  It is a common cancer that can spread or metastasise to the lymphatic 
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nodes of the body (Allan et al., 2008; Balch et al., 2001; Iannacone et al., 2015; Poole & 
Guerry, 2005). If melanoma spreads to the groin/pelvic nodes, it is considered to be stage 
III MM (Balch et al., 2009) and the first line of curative treatment is surgery to remove the 
diseased nodes (ACN, 2008; Pasquali et al., 2012).  Australian figures estimate that 
between 350-400 people in Australia will undergo groin/pelvic node dissection for stage III 
MM annually (Spillane  et al., 2012).  The surgery is significant and in the short term, pain, 
wound infections, seroma and reduced range of motion (ROM) prevail (Faries et al., 2010; 
Serpell et al., 2003; Ul-Mulk & Holmich, 2012).  In the longer term, a negative and 
relatively common side effect of this surgery may be secondary lymphoedema of the leg, 
pubic region and even abdomen (Allan et al., 2008; Foldi & Foldi, 2006; Sarnaik et al., 
2009; Spillane et al., 2008; Theodore et al., 2017).  
Current literature in the field of MM has primarily focused on surgical outcomes and stages 
of melanoma (Allan et al., 2008; Glover et al., 2014; Hughes, A'Hern, & Thomas, 2000; 
Sabel et al., 2007; Sarnaik et al., 2009), psychological issues associated with melanoma 
including anxiety, depression and post -traumatic stress during diagnosis or through follow-
up (Kasparian, 2013a, 2013b; Kasparian, McLoone, & Butow, 2009; Kasparian et al., 
2012; Kelly et al., 1995; McLoone et al., 2013), and coping mechanisms required for the 
individual and significant others (Kasparian et al., 2009; Oliveria et al., 2013; Tan et al., 
2014). The physical and psychological impacts of melanoma diagnosis and consequent 
treatments have received greater attention in the past decade (Tan et al., 2014) whilst the 
implication on occupational performance of an individual has been relatively unexplored.  
LLL is a potential side effect of the surgery that has received far less research attention 
than the disease processes of melanoma itself or arm lymphoedema as an outcome of 
breast cancer.  Lymphoedema is a chronic condition that manifests as swelling of a body 
part(s) due to disruption or damage of the lymphatic system (Foldi, 2006) and is a feared 
complication of cancer treatments (Meiklejohn, Heesch, Janda, & Hayes, 2013; Shih et 
al., 2009). Secondary lymphoedema from cancer is one of the most common causes of 
lymphoedema in the western world (Williams, Franks, & Moffatt, 2005).  Researchers 
acknowledge that lymphoedema and post-surgical complications in the lower limb (LL) 
are more prevalent than in breast cancer related lymphoedema (BCRL) of the upper limb 
(UL) following axillary dissection (Faries et al., 2010; Serpell et al., 2003; Ul-Mulk & 
Holmich, 2012).  
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Following surgery for removal of lymph nodes in the groin/pelvis, people may experience 
difficulties with walking, sitting, standing and the ability to return to activities of daily living 
or vocational roles. Physically, LLL may result in any combination of symptoms including 
limb swelling, heaviness, tightness, pain, impaired sensation and/or function of the 
affected limb (Foldi & Foldi, 2006; International Lymphoedema Framework, 2006). It has 
also been associated with fibrosis and recurrent episodes of infection or inflammation 
(Preston, Seers, & Mortimer, 2004; Soo, Bicanic, Heenan, & Mortimer, 2008; Szuba & 
Rockson, 1998) and for the LL, issues of lymphorrhoea, where lymphatic fluid leaks out 
of an oedematous limb,  can occur in later stages (Foldi & Foldi, 2006). Psychosocial 
issues reported as negative consequences of lymphoedema include distress, depression, 
anxiety, frustration, changes in role function, reduced social support, impaired body 
image and social avoidance and these impact on quality of life (Boyages et al., 2016a; Fu 
& Kang, 2013; Lemieux et al., 2011; Leung, Tirlapur, & Meads, 2015; Lloyd et al., 2014; 
Stolldorf, Dietrich, & Ridner, 2016). Further challenges following management of LLL 
following nodal dissection for MM can be found on page 13/14 of the thesis. 
Treatment of lymphoedema is intensive. The current gold standard treatment for 
established lymphoedema in any part of the body is Complex Decongestive Therapy 
(CDT) which involves education regarding the condition and management, skin care, 
compression bandaging, manual lymphatic (MLD) drainage and exercise (Foldi & Foldi, 
2006; International Lymphoedema Framework, 2006; Preston et al., 2004). This normally 
involves an intensive physical treatment phase of between 2-4 weeks of daily therapy 
with a qualified lymphoedema therapist.  During the subsequent maintenance phase 
which is life-long, the patient continues daily wearing of compression garments and 
ongoing daily self-lymphatic drainage (SLD), exercise, weight management and skin 
care.  Review appointments will occur between 3-month and 12-month intervals for the 
rest of the person’s life and often a person will require further intensive bouts of intensive 
therapy if they experience any exacerbation of symptoms.   
The consequent negative impacts of LLL on quality of life (QoL), (Cromwell et al., 2015; 
Dunberger et al., 2013; Williams, Moffatt, & Franks, 2004) or health-related quality of life 
(HRQoL), (Montazeri, 2008; Morgan, Franks, & Moffatt, 2005), have led to many 
advocates favouring proactive, preventative approaches.  Recommendations have 
included prophylactic wearing of compression garments post-surgery (Sarnaik et al., 
2009; Spillane et al., 2008), teaching of simple lymphatic drainage (SLD) and exercises 
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(Chang & Cormier, 2013; Fukushima et al., 2017; Reul-Hirche, 2011), risk management 
practices such as avoiding medical procedures on the operative limb (Clark, Sitzia, & 
Harlow, 2005; International Lymphoedema Framework, 2006; NLN., 2008), avoiding 
extreme temperatures (NLN., 2008) and other such recommendations. Some of these 
recommendations have been criticised for lacking rigorous scientific evidence (Cemal, 
Pusic, & Mehrara, 2011; McLaughlin, 2012) and require further research to confirm or 
refute claims.  
There are very few studies that have assessed proactive, preventative approaches for 
lymphoedema and none sufficiently examined the impacts, potential burdens or benefits 
perceived by people participating in such activities.  More high-level evidence is required 
to demonstrate the efficacy of approaches for lymphoedema prevention.  There are also 
gaps in documented studies pertaining to burden of treatment and impacts on 
occupational performance regarding intense lymphoedema treatment, surveillance or 
preventative programs, for people with stage III MM of the groin/pelvis. Quantitative 
papers have dominated the field, but rigorous qualitative work is also acknowledged as 
providing an important insight into people’s experiences far beyond what can be captured 
by quantitative research methods.  Qualitative papers are emerging in terms of 
perceptions and experiences of melanoma specifically (Tan et al., 2014) and 
lymphoedema treatment (Williams et al., 2004). Whilst research in the areas of 
preventative therapies to minimise/reduce lymphoedema (in the upper and lower limbs) 
remains important, the impact of these early intervention programs or relevant 
surveillance models from the patient’s perspective also needs to be considered – does 
burden of intervention outweigh benefit to the individual? Gaps remain in our 
understanding of the burden of treatment and prevention of lymphoedema and its impact 
on occupational performance, particularly for people following surgery for stage III MM of 
the groin.   
This thesis will therefore examine the experiences, occupational performance impacts 
and perceived needs of people undergoing groin/pelvic node dissection for stage III MM -  
including those undergoing a prevention treatment approach and those in a 
monitoring/surveillance group for lymphoedema. Using an interpretive descriptive (ID) 
approach (Thorne, 2008), our understanding of the needs of this specific group may be 
enriched.  An understanding of how the conditions, surgery, preventative treatment 
and/or monitoring impact on occupational performance could inform provision of optimal 
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support, education and guidance, ultimately leading to improved planning and delivery of 
services. 
1.2 THESIS AIM 
 
To explore the experiences, occupational performance impacts and needs of people who 
are at risk of, or have developed lymphoedema following inguinal (groin) or ilio-inguinal 
(groin/pelvic) node dissection for stage III metastatic melanoma. 
1.3 RESEARCH QUESTIONS 
1. What are the experiences, impacts and needs of people with stage III MM following 
surgery to the groin/pelvis? 
2. What are the experiences of monitoring and proactive, preventative approaches for LLL 
following surgery for stage III MM?  
 
1.4 THESIS CHAPTER OUTLINE 
This thesis is comprised of 5 chapters.   
Chapter 1 presents the rationale for this thesis and outlines the specific aim and structure 
of the thesis by chapters. Chapter 2 is a literature review that outlines the physical, 
psychosocial, quality of life and documented occupational performance issues for people 
undergoing surgery for MM as well as those same issues for people with LLL. It will 
identify current gaps in the literature regarding prevention, surveillance and treatment of 
LLL of people who have undergone lymph node dissection for stage III MM of the groin 
and are at risk of or have developed LLL.  Chapter 3 presents the methodology for the 
study that forms the basis of this thesis: a qualitative study with people who have had 
pelvic/groin surgery for stage III MM. Chapter 4 documents the findings of this interpretive 
descriptive study. Finally, chapter 5 discusses the findings of this study and compare it to 
what is already known.  The potential implications for therapists working with this patient 
group in the clinical setting and for future research will be presented. 
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CHAPTER 2: MELANOMA AND LYMPHOEDEMA 
This chapter outlines the impacts of MM and consequent development of LLL in people 
having surgery for stage III MM of the groin and/or pelvis. Without first understanding MM, 
it is not possible to move forward to discuss LLL in this group of people.  Therefore, 2.1. 
will initially define MM, overview prevalence and treatment data to enable the reader to 
comprehend the complexities and implications of treatment for people with MM who have 
surgery and are then at risk of, or develop, LLL.  Section 2.2 will follow the journey of a 
stage III MM survivor and describe the physical and psychological impacts of MM.  
Section 2.3 will define and outline issues for LLL.  Quality of life and occupational 
performance issues for both conditions will also be discussed.  A brief outline of current 
LLL treatments and evidence relating to prevention of lymphoedema will be discussed in 
2.4 and 2.5.  The remainder of the chapter will outline gaps in the literature, particularly 
regarding occupational performance issues, lymphoedema surveillance and prevention.     
2.1. MELANOMA AND METASTATIC MELANOMA 
Melanomas are malignant tumours that  are most commonly seen as moles or on the skin 
(skin melanoma), but can also begin in other pigmented tissues, such as in the eye, 
mucosa/ intestines, vulval and anorectal mucosa and the central nervous system (Perera, 
Gnaneswaran, Jennens, & Sinclair, 2014). Worldwide figures estimate that approximately 
232 000 new cases of melanoma are diagnosed each year (International Agency for 
Research on Cancer, 2012) and the World Health Organisation (WHO) report 
approximately 48 000 melanoma-related deaths annually.  Fortunately, there has been a  
documented increase in overall 5-year survival for people with melanoma (ACN, 2008). 
Despite melanoma rates in Australia and New Zealand starting to plateau in recent years 
(Whiteman, Green, & Olsen, 2016) Australian prevalence figures remain the highest in the 
world, being  three times higher than the United States and two times higher than the 
United Kingdom (ACN, 2008). Most up-to-date figures (AIHW, 2016) document that in 
2012, the number of newly diagnosed cases of melanoma in Australia was 12, 036 (7,060 
males and 4,976 females) and subsequent Australian mortality figures in 2013 were 1,617 
(1,107 males and 510 females).  Melanoma accounts for only 2.3% of all skin cancers but 
it is responsible for 75% of all skin cancer related deaths so its impact is significant.  
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Melanoma is a common condition and severity is based on a staging classification system 
set up by the American Joint Committee on Cancer (AJCC) which considers tumour 
thickness, ulceration and cell division rates (Balch et al., 2009). Localised melanoma that 
has not spread to the lymphatic nodes is considered stage I or stage II melanoma.  The 
majority of these melanomas are surgically removed with a margin of 5mm to 1cm 
minimum margin of clear skin between tumour and normal surrounding skin (Perera et al., 
2014).  Survival rates for thin, stage I or II melanoma’s is high with a 5-year survival figure 
of >94% (Homsi, Kashani-Sabet, Messina, & Daud, 2005) but deeper melanomas such as 
stage IIC melanomas have lower survival rates (Balch et al., 2009). Thin melanomas have 
no reported incidences of lymphoedema as the localised surgery to remove the 
melanoma does not routinely impair lymphatic function. 
This thesis focuses specifically on people with stage III MM of the groin/pelvis which 
occurs when primary melanomas of the lower limb (LL) or torso, spread into the groin 
and/or pelvis (ilio or ilio-inguinal) lymphatic nodes (ACN, 2008; Balch et al., 2009).  In 
Australia, approximately 350-400 people are diagnosed with stage III MM of the groin 
annually (Spillane  et al., 2012). When melanoma metastasises, there are further 
implications for survival. In cases of primary melanomas removed from the LL or torso, 
the groin/pelvis (ilio or ilio-inguinal) lymphatic nodes are the most common site of 
recurrence for metastatic disease (ACN, 2008; Balch et al., 2009). Stage III MM is 
confirmed if lymphatic node(s) of the groin are enlarged, can be manually palpated, and  
cancer is detected by fine needle biopsy (Balch et al., 2009). International 5-year survival 
rates within sub-stages of stage III are 78% for stage IIIA, 59% for IIIB and 40% with 
stage IIIC MM. For people who survive longer term, the condition could be considered an 
emerging chronic disease (Cornish et al., 2009) and with the breakthrough of medical 
interventions, survival times are increasing. Surgical intervention is recognised as the first 
line of curative treatment and therefore an inguinal (groin) node dissection or more 
extensive Ilio-inguinal (groin and pelvic) node dissection is conducted (Glover et al., 2014; 
Theodore et al., 2017) .  People who undergo surgery to remove these nodes are at high 
risk for LLL because of the damage to their lymphatic system (Allan et al., 2008; Faries et 
al., 2010; Foldi & Foldi, 2006; Poos et al., 2009; Spillane  et al., 2012).  
People with stage IV MM are not included in this study.  This group have a poor overall 
prognosis with figures suggesting a 1-year survival rate of between 33%-62% (Balch et 
al., 2009).The survival rate drops further to between 7-12 months if melanoma has 
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reached the viscera (Balch et al., 2001). Multidisciplinary specialist care and palliative 
care are paramount for people in this stage of MM with use of surgery, radiation, 
immunotherapy and chemotherapy also possible.  
2.2 STAGE III MM FROM DIAGNOSIS TO SURGERY AND SURVIVAL 
2.2.1 Melanoma Diagnosis – The Psychological Impact  
It is recognised that the diagnosis of cancer of any description is a stressful event in the 
life of an individual and their family (WHO, 2002) and the diagnosis of stage III MM is 
potentially a life-limiting diagnosis.  Research and clinical findings have suggested that the 
diagnosis of melanoma may impact on all aspects of an individual’s life from their 
perceived well-being, body image and sense-of-self to work or occupational roles, career 
and finances as well as social relationships (Kasparian et al., 2012; McLoone et al., 2013) 
and therefore health-related quality of life (Cornish et al., 2009). This section will consider 
the psychological impact of MM diagnosis and its treatment on MM survivors.  
“Survivorship” in cancer, and in this instance MM, means different things to different 
people.  For some, the term reflects having no signs of cancer following treatment whilst 
for others it includes the process of living with, through and beyond cancer (ASCO., 2017)  
In this thesis, survivorship will be considered in this way.  As such, survivorship is a 
complex issue that has different impacts on individuals.   
 2.2.2 Melanoma – Anxiety and Depression 
Anxiety and depression are frequently reported outcomes for people during their journey 
of MM diagnosis, management and treatment.  These conditions are the most commonly 
reported mental health concerns of melanoma survivors across varying degrees of 
severity (Brandberg, Månsson-Brahme, Ringborg, & Sjödén, 1995)  A systematic review 
(Kasparian et al., 2009) reports that approximately 30% of people with a melanoma 
diagnosis scored  emotional distress ratings that should be addressed by professional 
clinical intervention. This review combined 44 studies across all stages of melanoma, 
incorporating metastatic and non-metastatic disease.   Variances of prevalence rates of 
distress exist across studies, and Kasparian et al. (2009) suggested that this may be due 
to differences in study samples, time-frames of assessments, numbers and types of tools 
utilised for assessment, failures to adjust for disease severity, and small sample sizes or 
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study design. Additionally, distress can alter over time and be impacted by many events in 
a person’s life.  Prevalence figures in Kasparian et al.’s review (2009) suggest that anxiety 
rates for melanoma are approximately 23% and 11% for depression.  This is higher than 
the anxiety and depression figures in the general Australian population data.   Australian 
Bureau of Statistics (2008) data reports that 14% of all Australians aged 16-85 years 
experienced anxiety whilst 6% of the population experienced depression/affective 
disorders.  The incidence of anxiety with melanoma was higher in women than men (Al-
Shakhli, Harcourt, & Kenealy, 2006; Beutel et al., 2015; Holterhues et al., 2011) and was 
more significant in the period just after diagnosis (Ko, 2003).  McLoone et al. (2013) 
confirmed that uncertainty and fear of recurrence of melanoma are concerns for this 
group.   
Various factors have been suggested as potential predictors of higher distress in 
melanoma and should be considered during treatment as potential barriers to how people 
cope.  These include lower levels of education (Hamama-Raz & Solomon, 2006; 
Kasparian et al., 2009) , being young  (Bergenmar, Nilsson, Hansson, & Brandberg, 2004; 
Missiha, Solish, & From, 2003), having limited social supports or being unmarried (Beutel 
et al., 2015; Hamama-Raz & Solomon, 2006; Sollner et al., 1998), unemployment or 
having a poor subjective belief in one’s ability to cope (Sollner et al., 1998), and being 
female (Bergenmar et al., 2004; Missiha et al., 2003; Trask & Griffith, 2004). The gender 
issue remains unclear, with inconsistent data regarding gender differences and levels of 
psychological distress, fear of recurrence, body image concerns and quality of life.  A 
recent study reported no differences between male and females regarding perceptions of 
anxiety and depression after melanoma diagnosis (Palesh et al., 2014), whilst other 
researchers (Atkinson et al., 2013; Beutel et al., 2015; Holterhues et al., 2011)  have 
reported that women rate more poorly than their male counterparts with the same 
diagnosis for anxiety and depression.  
2.2. Melanoma – Post-traumatic Stress Disorder  
An alternate view is that people living with a diagnosis of melanoma are not experiencing 
anxiety per se, rather they experience psychological impacts like those described in a 
post-traumatic stress framework as they are facing potential death (Horowitz, Wilner, & 
Alvarez, 1979; Kelly et al., 1995; Sollner et al., 1998). The initial diagnosis is followed by 
surgery, many medical visits, the fear of recurrence (particularly within a two-year time 
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frame) and the knowledge that any visit could reveal devastating news.  A cross-sectional 
study of 95 individuals across all stages of melanoma in Queensland (Kelly et al., 1995) 
investigated responses on both the Hospital Anxiety and Depression Scale (HADS) 
(Zigmond & Snaith, 1983) and the Impact Event Scale (IES) to determine levels of anxiety 
and depression as well as incidence of issues with potential Post traumatic Stress 
Disorder (PTSD).  Data indicated  PTSD occurrence was greatest in people with stage III 
MM (Kelly et al., 1995), but no significant differences between anxiety and depression 
were found between the melanoma stages. The authors cautiously concluded that the 
IES, a tool to measure PTSD, may be a more sensitive tool to highlight stress along the 
course of the melanoma continuum rather than anxiety and depression scales.  The Kelly 
et al. study (1995) and another study (Brandberg, Bolund, Sigurdardottir, & Per-Olow, 
1992) concurred that anxiety symptoms were more prevalent  than depression across all 
participant groups however both studies were unable to identify significant differences 
between non-metastatic and MM groups on the HADS-anxiety index and this is consistent 
with other findings.  
2.2.4 Melanoma – Unmet Needs 
Distress and anxiety may be heightened when a person feels their needs have not been 
met or their knowledge is inadequate to deal with a situation that they find themselves in 
(Ormandy, 2011).  People across all stages and locations of MM disease have expressed 
moderate to high unmet needs including unmet information and support needs (Bird, 
Coleman, & Danson, 2015; Bonevski et al., 1999; Hetz & Tomasone, 2012; Passalacqua 
et al., 2012) and reported needs fluctuated according to stage of melanoma, time since 
diagnosis, prognosis of survival and whether recurrence occurred (Boyle, 2003). Many 
studies combine people with stages I-III in their results (Hamama-Raz & Solomon, 2006; 
Holterhues et al., 2011; Kasparian et al., 2009; Oliveria et al., 2013; Trask et al., 2001) 
which may confound reporting of unmet needs at each stage.  People with stage I and 
stage II invasive melanoma were found to have high psychological distress, support and 
health information needs at diagnosis, but these needs subsided over time unless a 
recurrence occurred (Beesley et al., 2017; Beesley et al., 2014).  Bonevski and 
colleagues (1999) examined five domains of need (psychological, health information, 
physical and daily living, patient care and support and interpersonal communication) using 
the Cancer Needs Questionnaire (Foot & Sanson-Fisher, 1995) with people in stage I and 
early stage II melanoma and found that six out of the top ten ranked needs were related 
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to health information.  The study focused primarily on health information deficits and whilst 
it was reported that 40% of respondents indicated they may have some need in the 
physical and daily living domain during their 2-year follow-up, no further details were 
provided in their paper. It could be postulated that people diagnosed with stage III MM 
may perceive different unmet needs than people in stage I or II. 
A qualitative study by Tan et al. (2014) identified unmet needs specifically for people with 
stage III MM including poor communication, problems with physical, functional and 
emotional issues, concerns regarding metastases, recurrence, disfigurement and 
reactions from others. Fear of cancer recurrence  (Vickberg, 2003) is highly reported in 
this group and evidence suggests fear of cancer recurrence and psychosocial well-being 
or HRQoL are negatively correlated (Koch, Jansen, Brenner, & Arndt, 2013). Qualitative 
research conducted across various stages of melanoma also report that people with 
melanoma feel they are different to people with other cancer diagnoses and that because 
they appear healthy, people may dismiss their fears or concerns (Lee-Jones, Humphris, 
Dixon, & Hatcher, 1997). Due to the poor prognosis, the needs of people with stage IV 
has been studied separately and research has focused on the unmet needs in the 
palliation phase (Jones et al., 2015). 
 2.2.5 Coping with Melanoma 
With such an array of factors potentially influencing distress levels in people with 
melanoma, researchers have suggested that psychosocial variables such as people’s 
coping styles may play a role in managing distress and may even impact survival in MM 
(Brown & King, 2000; Butow, Coates, & Dunn, 1999).  The psycho-oncology literature 
identifies three general coping styles which include (1) active-behavioural coping where 
there are conscious behavioural attempts to deal with the condition and its effects, 
including relying on others for support; (2) active-cognitive coping which encompasses  
one’s belief’s, attitudes and perceptions about cancer; and (3) avoidance coping, where 
active avoidance of the problem or means of distraction are used (Kasparian et al., 2009).   
Research suggests that people who use active strategies report better adjustment than 
those who utilise avoidant or passive coping styles (Kasparian, 2009).  Specifically, those 
who were optimistic about surviving, had less negative  impacts on their day to day lives, 
or vented their emotions, had  lower relapse times and higher survival rates (Butow et al., 
1999) when compared to those who used avoidance or non-expression.   
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An Australian qualitative study examined the psychosocial impacts and coping strategies 
of 19 people with stage III MM who had been diagnosed between 6-months and 3-years 
previously and 14 of their caregivers (Tan et al., 2014).  Using semi-structured interviews, 
the study documented the impact of diagnosis, treatment and experiences in both the 
acute and extended survivorship of individuals with axillary and groin/pelvic stage III MM. 
In this study, authors categorised acute survivorship as encompassing the period of 
diagnosis and initial treatment.  The period after this time was considered extended 
survivorship. Tan and colleagues (2014) reported that people coped in different ways 
according to the time since diagnosis.  Following diagnosis of MM, people in the study 
experienced shock, panic and devastation.  An initial coping strategy was avoidance, but 
this was abandoned as they adjusted to the realities of the diagnosis. Treatment impacts 
included challenges with “unsatisfactory care, pain and limitation, practical issues, new 
roles and responsibilities for caregivers and caregiver inadequacy”.  Coping mechanisms 
included relinquishing responsibility to experts in the field or taking an active approach in 
seeking assistance or alerting others of their need for assistance.  
 
During extended survivorship, people identified ongoing physical problems, a feeling of 
watchful waiting and feeling abandoned by the medical teams (Tan et al., 2014).  During 
this time people coped best by finding a positive meaning from cancer survival, such as 
being more appreciative of family, and placing emphasis on healthy, fulfilling lifestyles.  
Others reported an acceptance of their current state and acknowledged that death was a 
potential outcome but being at peace with the life they had already lived.  Some 
compartmentalised the experience and attempted to return to normality once cancer 
treatment was completed.  Issues such as emotional distress, disfigurement, injustice and 
caregiver devaluation were raised throughout all phases from diagnosis to survivorship 
and coping strategies included receiving support from professionals, family and friends, 
helpful or positive thinking, putting on a brave face, redirecting attention and having a 
spiritual faith (Tan et al., 2014).  The findings from the study suggested that routine 
screening for physical symptoms and psychological distress would be beneficial for this 
group.   
In summary, psychological distress (anxiety, depression or PTSD) may be significant 
problems for people who are diagnosed with melanoma at any stage. High levels of 
distress across melanoma have been associated with reduced motivation to seek medical 
attention and therefore potentially hastening mortality through disease progression, slower 
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recovery, increased morbidity, greater strain on carers and family, and higher financial 
implications regarding care (de Braud et al., 2003; Kneier, 2003).   
2.2.6 Stage III MM- Sequelae of Ilio-inguinal Node Surgery and Other Treatments  
Surgery for people diagnosed with stage III MM of the groin is extensive, with the potential 
for significant side-effects and morbidity (Allan et al., 2008; Chang et al., 2010; Moody et 
al., 2017).  Physically, lymph node dissections, regardless of location, result in symptoms 
of post-operative pain, tenderness and wound exudate proliferation in the acute phase 
following surgery (Chang et al., 2010; de Vries, Vonkeman, van Ginkel, & Hoekstra, 2006; 
Faries et al., 2010).  Some researchers report that wound morbidity following inguinal 
node dissections is higher than axillary node or neck dissections for MM. Additionally, LLL 
risk and prevalence is higher with inguinal/ilioinguinal node dissection versus axillary node 
dissection.  Wound complications rates ranged from 25%-90% (Hughes et al., 2000; 
Hughes & Thomas, 1999).  Surgeons, lymphoedema specialists and researchers alike 
have hypothesised that there may be a link between early wound complications and 
lymphoedema (Foldi & Foldi, 2006; International Lymphoedema Framework, 2006; Spratt 
& Donegan, 1995).  In general, prospective studies reported higher incidences of wound 
complications and LLL than studies reported retrospectively (Hughes et al., 2000; Sabel et 
al., 2007; Ul-Mulk & Holmich, 2012) with the exception of de Vries (de Vries et al., 2006) 
who reported that 64% of 66 participants undergoing lymph node dissection of the groin 
experienced LLL but had lower incidence rates for infection, seroma and wound 
dehiscence.  
Even when wounds have healed, the surgical scarring following inguinal or ilio-inguinal 
node dissection is extensive (see Figure One) due to the large amount of tissue disruption 
that is required to access and remove the lymphatic nodes in the groin (inguinal) or pelvis 
and groin (ilio-inguinal) basins. Due to the wound/scar extending over the inguinal crease, 
mobility in the early days post-surgery is impacted and the drain exiting from the surgical 
area impedes free movement (Sarnaik et al., 2009). These complications provide 
challenges, frustrations and potential physical, psychological and financial burden for the 
individual and their treating teams whilst also impacting financially on the health care 
system (Chang et al., 2010). 
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Figure One: Right ilioinguinal node dissection for stage III MM. Left, day of operation and 
right, 2 days after.  Reprinted with signed consent of participant and surgeon. 
The physical and psychological impacts that have been attributed to the diagnosis and 
subsequent surgery for various stages of MM are significant and have been shown to 
impact negatively on QoL. However, many of these documented studies focus on stage I 
and II MM (Beesley et al., 2017; de Vries et al., 2009) where surgery is less invasive and 
survival rates can be relatively high or stage IV (Robinson et al., 2012) where prognostic 
outcome is very poor.  Research focused specifically on stage III is limited and this is 
important as the survival rate for this group varies from stages I and II and treatments also 
vary for those who are in stage IV MM.  In the short-term following surgery for stage III 
MM, pain and reduced ROM affect functional and social activity (Cornish et al., 2009).   
However, few studies have directly explored the impact of stage III MM on a person’s 
occupational performance across the domains of productivity, self-care or leisure.  The full 
extent of impact that chronic conditions such as LLL may have on people’s lives requires 
further exploration. 
Additional factors to consider in long-term treatments for melanoma include the impacts of 
adjuvant therapies for stage III MM, including immunotherapy and targeted therapies and 
to a lesser extent, chemotherapy and radiation.  Debate continues regarding the 
effectiveness of radiation for MM, due to the high toxicity rate (45%) and inconclusive 
evidence of improving regional control or overall survival (Bibault et al., 2011).  
Checkpoint immunotherapy aims to enhance the immune system response thereby 
maximising the ability to locate and attack cancer. Side effects from checkpoint inhibitors 
may be severe and may result in inflammatory responses (Rodríguez-Cerdeira et al., 
2017). Targeted therapies are drugs which aim to inhibit tumor growth by blocking specific 
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damaged proteins and inhibit further progression of the disease by blocking tumor cell 
proliferation (Karachaliou et al., 2017).  Modern, targeted therapies aim to block mutated 
BRAF gene proteins and have found to be effective across all stages of MM, but 
particularly in stage III and IV, with ongoing research to determine the best combination, 
dose and duration of treatment (Long et al., 2017; Rodríguez-Cerdeira et al., 2017). Many 
people with melanoma are now treated with a combination of immunotherapies and 
targeted therapies and further research is required to determine the most effective 
combinations to minimise side effects whilst maximising therapeutic outcome (Karachaliou 
et al., 2017). 
Currently, the side effects of chemotherapies, immunotherapies and radiation are known 
to exist (Karlsson & Saleh, 2017) and are concerns for specialists (Jones et al., 2015) but 
variability remains with some people experiencing fatigue and physical symptoms, and 
others not being impacted as significantly.  The impacts on HRQoL (Schadendorf et al., 
2017) and economic costs of MM (Elliott, Whiteman, Olsen, & Gordon, 2017) is reported 
on, but specific occupational performance issues remain under-reported. 
2.2.7 Metastatic Melanoma and Occupational Performance 
Many MM studies focus primarily on treatment options for each stage of MM.  Impacts on 
daily living or occupational performance, if mentioned, are noted as secondary outcomes, 
and studies rarely explore the different issues that may arise as a direct result of MM 
diagnosis, surgery and coping versus the impacts of LLL.  A dated qualitative nursing 
study conducted content analysis of interviews of 60 people with melanoma at various 
stages and locations (Longman & Graham, 1986).  Participant’s ages, adjunctive 
treatments, marital status and employment status varied, ensuring that many differing 
perspectives were captured during interviewing. Six categories, each with subsequent 
themes emerged from the data and included “Living with Cancer; Thoughts about 
Treatment for Melanoma; Changes in Making Life Meaningful; Alterations in Life-Style; 
Relationships with Others; and Social Support Adaptation”. Themes such as “Alterations 
in Life-Style” commented on physical issues (e.g. no longer being able to wear regular 
clothing), impacts on social engagement (independence levels, level of activity) and even 
alterations in finances (e.g. reduced finances and not going out for meals) that one might 
assume are associated with lymphoedema.  However, lymphoedema was not mentioned 
during the paper.  Despite the rich descriptive data providing a platform for positive and 
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negative aspects of melanoma to be discussed, it seems that there may have been a 
missed opportunity to explore experiences related to melanoma versus lymphoedema.   
Tan et al. (2014) studied the psychosocial impact, coping and adjustment in individuals 
with stage III MM and their caregivers experienced during their melanoma journey. Whilst 
they reported various qualitative themes from diagnosis to survivorship and identified that 
many issues impact directly on people’s roles and responsibilities in daily life, they 
stopped short of discussing occupational performance at length. Extrapolation of impacts 
due to MM versus lymphoedema were not outlined, although the researchers did 
acknowledge that lymphoedema was an issue following MM surgery.  
In summary, few papers have explored occupational performance in-depth, with 
qualitative studies focusing on reactions at diagnosis and coping mechanisms throughout 
melanoma follow-up. Equally, few studies have been able to identify the potentially 
different impacts of MM and LLL.  
2.3 LYMPHOEDEMA 
Lymphoedema is swelling that develops due to a build-up of fluid and other debris (e.g. 
protein) in the tissue spaces.  This is due to a mismatch between interstitial fluid 
production and transport (Foldi & Foldi, 2006; International Lymphoedema Framework, 
2006; ISL, 2009).  That is, fluid and proteins or other debris are not able to be removed 
from the tissues due to damage to the lymphatic system and therefore swelling of the area 
may occur. It is classified as either genetic (primary lymphoedema) or, as is the case in 
this present study, secondary lymphoedema due to damage or disruption to the lymphatic 
vessels and/or lymph nodes (Foldi & Foldi, 2006). It is unable to be cured and is 
considered a chronic disease that is requires life-long management (ISL, 2009; Thomas & 
Hamilton, 2014) . Worldwide prevalence figures for all types of lymphoedema are 
estimated to be between 140 to 200 million people (Greene, 2015).  Many believe these 
figures may be underestimated  (Moffatt et al., 2003) but it is recognised that secondary 
lymphoedema from cancer is the most common cause of the condition in the western 
world. The prevalence of secondary LLL following nodal dissection for MM is significant 
but reported prevalence rates range from 6-66% (Allan et al., 2008; Cormier et al., 2010; 
Spillane et al., 2008; Williams et al., 2005). Variances exist as there is no universally 
accepted “gold standard” definition for LLL, methods of measuring LLL across studies vary 
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and reporting is inconsistent.  It is also important to note that much of lymphoedema 
research relates to BCRL and therefore LLL has received far less attention.   
 
Complicating matters further, the measurement standards and definitions for LLL are 
variable.  Spillane et al. (2008) used classification and regression tree analysis to propose 
that a percentage change of greater than or equal to 7% when circumferences were 
measured at six defined sites along the leg or a 15% whole limb perometer volume change 
indicated LLL.  The ISL guidelines for rating severity of lymphoedema suggest limb volume 
differences as follows: mild (<20%), moderate (20%–40%) and severe (>40%). 
Additionally, the ISL proposed a four-level classification about stages of lymphoedema. 
These stages are guidelines and reflect the physical condition of a limb(s) and more than 
one stage may be present at once.  Stage 0 (or Ia) refers to a subclinical condition where 
swelling is not yet detectable, however subjective changes may be reported by the 
individual. Subtle tissue composition changes may be occurring but undetectable visually 
or by circumferential measurement.  Stage I represents an early accumulation of fluid and 
pitting oedema may occur.  This normally subsides with elevation. Stage II lymphoedema 
exists if limb elevation ceases to improve the swelling and consistent pitting occurs. 
Characteristics of late Stage II lymphoedema include less pitting, increased subcutaneous 
fat and the development of fibrosis.  Stage III is characterised by lympho-static 
elephantiasis where tissues no longer pits, and trophic skin changes develop (ISL, 2013).  
 
Many measurement tools have been used for assessing, measuring and monitoring 
lymphoedema and include water displacement, tape measures, perometry, bioimpedance 
spectrometry (BIS), tonometers and patient reported outcomes.  The diagnostic criteria for 
each measurement tool are as follows:  
(a) circumferential measurement changes of anywhere from 1-5cm from baseline or 
compared to the contralateral limb as potentially being indicative of lymphoedema 
(Armer & Stewart, 2005; Disipio, Rye, Newman, & Hayes, 2013; Hayes et al., 2008; 
Hidding et al., 2016);  
(b) limb volume differences from 5% or above based on either change in pre-to 
post-operative measures of the ipsilateral limb or using the heathy contralateral limb 
as a reference point; 
(c) perometry changes (Bundred et al., 2015; Moseley, Piller, & Carati, 2002);  
(d) bioimpedance spectrometry (BIS) changes of 10 points (Bundred et al., 2015; 
Dylke et al., 2012; Maho et al., 2013);  
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(e) water displacement, usually of >200ml (International Lymphoedema Framework, 
2006; Lopez Penha et al., 2011); 
(f) moisture meter readings (Mayrovitz, Weingrad, & Davey, 2014) or  
(g) tonometry changes (Haesler, 2015). 
  
Origins of cut-offs for some of these diagnostic criteria, particularly circumference and 
volume differences, lack scientific basis (Dylke et al., 2012)  and there are no distinctions 
between ULL and LLL.  With the UL and LL being quite different in terms of size, volume 
and function, future research regarding LLL definitions will be required to determine 
whether the current practice of using existing criteria is a reliable and valid practice. In a 
systematic review of measurement instruments for lymphoedema (Hidding et al., 2016) 
recommendations were made that BIS, volumetry, tape measurement and perometry 
could be recommended in clinical practice but consideration of lymphoedema stages 
should be given with BIS being considered most appropriate in stage I.  Additionally, whilst 
water displacement demonstrated low variance between measures and has been viewed 
as gold standard (Hidding et al., 2016; International Lymphoedema Framework, 2006), the 
practical use in clinical settings is difficult and therefore other tools are commonly used 
that are more time effective in use and set up, are cost effective and still have good 
reliability.  
The definition of LLL used in this thesis was a 10% limb volume difference between 
affected and unaffected legs in addition to a 10-point change from baseline BIS.  This was 
considered as a conservative measure of LLL, accounting for potential limb dominance 
differences whilst still meeting ISL guidelines of mild lymphoedema.  The potential of BIS 
in detecting sub-clinical thresholds of extracellular fluid is also recognised.  
Regardless of the definition or methods used to measure LLL, recognition exists that 
lymphoedema is commonly reported,  is a significant concern for people following 
treatment for cancer (Keeley, 2000) and remains one of the most feared consequences 
following cancer treatment (Fialka-Moser, Crevenna, Korpan, & Quittan, 2003; Morgan et 
al., 2005; Turner, Hayes, & Reul‐Hirche, 2004). There is a complexity in the journey for an 
individual from diagnosis of stage III MM, surgical intervention, and the subsequent period 
with the risk of the development of LLL. The associated morbidity that one or both 
conditions may have on physical, psychological, financial and occupational areas of a 
person’s life will be described in part two of this chapter.  
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2.3.1 Lymphoedema As a Consequence of MM Treatments 
Lymphoedema of the leg, genital region and/or abdomen as a secondary consequence of 
node dissection for stage III MM of the groin and/or pelvis, remains a significant problem 
(ACN, 2008; Allan et al., 2008; Faries et al., 2010; Theodore et al., 2017).  The necessary 
removal of lymphatic nodes during surgery results in disruption of lymphatics which for 
some, can result in a swollen, heavy limb that requires lifelong treatment and 
management (Foldi & Foldi, 2006; Szuba & Rockson, 1997).  For people who are already 
struggling to cope with a diagnosis of cancer, the onset and additional diagnosis of a 
chronic condition such as lymphoedema can add further physical, psychological, social, 
and financial complexity and burden to their life (Thomas & Hamilton, 2014; Williams et 
al., 2004). The reported trajectory of LLL in this cohort group has also been debated. 
Some surgeons have reported a pattern of LLL occurring early and then reducing or 
disappearing after 6-months (Spillane et al., 2008).  Burmeister et al. (2002) noted on 
average, maximum LLL was occurring at 14.7 months post-diagnosis and for people who 
received radiation after groin dissection surgery, this peaked earlier at approximately 5-
months.   
 
Debate continues regarding the types and extent of surgery in terms of the implications for 
LLL (Moody et al., 2017; Mozzillo et al., 2013).  Adjuvant treatments for people with stage 
III MM can include chemotherapy, radiotherapy and immunotherapy or combinations of 
these and questions remain as to whether these modalities may contribute to LLL.  
Radiation treatment can be used in inguinal nodal regions and may further  compromise a 
damaged lymphatic system (Henderson et al., 2015).   Debate continues as to whether 
radiotherapy is associated with increased LLL in MM. Some researchers report a positive 
correlation between radiotherapy and lymphoedema  (Henderson et al., 2015) whilst 
others have failed to find a correlation (Friedman et al., 2015). This raises the questions as 
to whether number of nodes removed, the dose and location of radiation might also be 
factors in lymphedema onset. Certainly, reports of higher incidences of LLL are reported 
by Henderson et al. (2015) and Bibault (2011) after inguinal node dissections followed by 
radiotherapy which were not seen in axillary dissections.  Increasing recognition of the  
effectiveness of systemic treatment (Karlsson & Saleh, 2017; Rodríguez-Cerdeira et al., 
2017), has resulted in reduced use of radiation in the treatment of stage III MM. 
Chemotherapy impacts are also debated with UL research suggesting a  contribution to 
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ULL (Norman et al, 2010) whilst others refute that claim (Swaroop et al., 2015).  A more 
commonly accepted risk factor associated with lymphoedema development is a high BMI 
(Greene, Frederick, & Slavin, 2012; Kwan, Darbinian, & Schmitz, 2010; Paskett, Dean, 
Oliveri, & Harrop, 2012)  due to lymphatic insufficiency and elevated body-mass index 
causing vessels to become dysfunctional and thereby reduce proximal lymphatic flow.   
2.3.2 Lymphoedema – The Physical Implications 
Physically,  lymphoedema may result in any combination of symptoms including limb 
swelling, visible lumps, puffiness or heaviness, tightness or hardness, pain, impaired 
sensation such as pins and needles, numbness, reduced function of the affected limb, 
increased risk of skin changes or skin infection and rarely the development of 
lymphangiosarcoma  (Foldi & Foldi, 2006; Preston et al., 2004). Research about the 
physical implications of lymphoedema primarily focuses on LLL after gynaecological 
cancers (Brown et al., 2014; Dunberger et al., 2013; Finnane, Hayes, Obermair, & Janda, 
2011; Fukushima et al., 2017; Iwersen et al., 2016; Tada, Teramukai, Fukushima, & 
Sasaki, 2009) and therefore relates solely to women. The experiences of women with LLL 
following gynaecological surgery, highlights physical symptoms including swelling, 
heaviness, various descriptions of pain and fatigue (Beesley et al., 2008; Finnane et al., 
2011; Rowlands et al., 2014). Qualitative interviews indicated that physical symptoms 
reportedly worsened in hot weather, when maintaining one position for too long or on long 
distance travel (Beesley et al., 2007; Ryan et al., 2003).  Such information regarding 
exacerbations of symptoms is refuted by some (Cemal et al., 2011; McLaughlin, 2012) 
who claim that there is insufficient high-level evidence to support such claims.  
The presence of physical symptoms due to LLL after surgery from gynaecological cancer 
has been shown to impede mobility, limit participation in general physical activity and daily 
walking (Brown et al., 2014) and generally increase functional impairment (Morgan et al. 
2005).  Brown et al (2014) utilised questionnaires and surveys to quantify associations 
between LLL, walking, and physical activity.  Data were collected from 213 American 
uterine cancer survivors and indicated that the presence of LLL was associated with 
poorer physical function.  Some researchers have reported that poor physical function 
impacts QoL, signifies a considerable barrier to functional independence, and predicts 
hospital admissions and premature mortality (Guralnik et al., 1994). These studies include 
only women following gynaecological surgery and therefore the results may not represent 
the experience of men with LLL. The remaining research includes people with a range of 
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different cancer diagnoses in which people with MM have poor representation, as do men 
(Towers, Carnevale, & Baker, 2008; Williams et al., 2004).   
An Australian study using a grounded theory qualitative approach conducted focus groups 
and telephone interviews with males (n=3) and females (n=26) mostly with breast or 
gynaecological cancer, to explore how people perceived and reported the impacts 
secondary lymphoedema had on everyday living (Meiklejohn et al., 2013). It was not clear 
if people with MM were included in this study. Thomas and Hamilton (2014) used 
interpretive description (I.D) in their qualitative work examining the impact of loss in adults 
living with secondary lymphoedema where four out of thirteen participants had LLL, but it 
was unclear if this was related to MM.  Two of the thirteen participants were male, but 
again, clarity as to whether they had LLL due to MM surgery of the groin was not evident.  
The findings of two studies including people with MM supports the evidence that 
lymphoedema negatively impacts physical function.  In a quantitative study by Cromwell et 
al. (2015), it was reported that ADL participation was affected for those with both ULL and 
LLL, however a greater negative impact was reported for people who had therapeutic 
lymph node dissection (TLND) and resultant LLL than in those having UL surgery.  Tan et 
al. (2014) reported qualitative findings from 19 people with stage III MM of the upper and 
lower limb and confirmed post-operative physical limitations, reduced functionality and 
independence were reported, however, the interplay between MM and lymphoedema was 
not clear. Both papers included people with axillary and ilioinguinal node surgery, with little 
detail as to the level of impairment that ensued. 
In summary, a paucity of literature exists regarding LLL and people with MM are poorly 
represented. Additionally, men with stage III MM are rarely represented in the literature, 
despite them having higher incidence and mortality data than women in terms of 
melanoma statistics.  Similarities might exist regarding physical impacts of LLL for people 
following gynaecological surgery and MM however differences might also exist in that men 
may perceive and report different outcomes.  Whilst physical symptoms are visibly evident 
for all to see, the psychological and emotional burden that people with secondary 
lymphoedema endure may be a hidden or “invisible” (Thomas & Hamilton, 2014) 
consequence but may be just as significant.  
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2.3.3 Lymphoedema– The Psychosocial Implications 
Lymphoedema can result in distorted body image, frustration, depression and anxiety and 
even guilt (Ahmed et al., 2008; Burckhardt, Belzner, Berg, & Fleischer, 2014; Ridner, 
Dietrich, & Kidd, 2011; Ridner et al., 2016; Taghian et al., 2014; Thomas & Hamilton, 
2014; Vassard et al., 2010). It may impact  social and intimate relationships of the person 
who is already coping with a diagnosis of cancer (McWayne & Heiney, 2005; Taghian et 
al., 2014; Winch et al., 2015) and can impact role, identity, function and social interaction 
(Barlow et al., 2014; Hamilton & Thomas, 2015; Meiklejohn et al., 2013; Miedema et al., 
2008; Winch et al., 2015).  Authors have made generalised statements regarding the 
impacts of lymphoedema, but again, most of this research was conducted with BCRL. In 
addition, the term “psychosocial impact” is broad, being defined in the Encyclopedia of 
Behavioural Medicine (2013, pg. 1583) as “the effect caused by environmental and/or 
biological factors on individuals’ social and/or psychological aspects”. Tan et al (2014) 
reported specifically on the psychological impacts of LLL for people with stage III MM, 
noting that physical dysfunction and disfigurement of scarring or a swollen limb resulted in 
negative body image, psychological distress and negatively impacted socially. Other 
studies involving UL and LLL have suggested that lymphoedema negatively impacts self-
identity, emotions and sexuality.  Issues such as marginalisation, economic burden, 
isolation, abandonment, public insensitivity and non-supportive work environments have 
been found to exist (Boyages et al., 2016a; Kusters, Williams, Obermair, & Janda, 2015; 
Winch et al., 2015) and these areas are more difficult to objectively measure.  
A systematic review of the literature from 2004-2011 (Fu et al., 2013) identified eleven 
quantitative and twelve qualitative studies that explored the psychosocial impact of 
lymphoedema. The studies predominantly included people with BCRL (i.e. ten of eleven 
quantitative and seven of twelve qualitative). There were no participants with LLL caused 
by MM surgery in the quantitative studies and it is unclear if there were any represented in 
the qualitative studies.  Findings of the review suggest that people with lymphoedema 
have statistically significant lower levels of social well-being, reporting negative 
perceptions of appearance, body image, appearance, sexuality and increased social 
barriers (Fu et al., 2013).  No statistically significant differences were found in the domain 
of emotional well-being and psychological distress when comparing people with and 
without lymphoedema. Quantitative studies generally use closed questionnaires, generic 
health-related quality of life (HRQoL) instruments and less frequently, disease specific 
23 
 
instruments in attempts to quantify psychological impact.  It could be postulated that some 
tools lack sensitivity or specificity (Fu & Kang, 2013) to draw out the relevant domains that 
people living with lymphoedema face.  
One study explored women’s views of care and treatment following lymphoedema 
diagnosis and included women with either ULL or LLL (Barlow et al., 2014).  Age ranges 
varied, as did clinical histories and services accessed, but responses were from females 
only, so gender bias must be considered and generalisation of outcomes with male 
counterparts is limited.  This study concurred that women felt “let down” regarding the 
information they received about the risks and management of lymphoedema; that a 
diagnosis of lymphoedema had a negative impact on their mental well-being and that like 
an earlier study (Carter, 1997), they had been “abandoned by medicine”.  The lack of 
knowledge and recognition by health professionals about the devastation and life-
changing impacts that lymphoedema brings with it was reiterated and the frustrations of 
diagnostic delay was consistent with subsequent studies (Posner & Momenzadeh, 2004; 
Ridner, Bonner, Deng, & Sinclair, 2012; Watts & Davies, 2016).  
These findings were reflected in a qualitative study using an ID methodology with semi-
structured interviews to explore the impact of loss in thirteen adults living with secondary 
ULL and LLL following a mixture of cancer diagnoses (Thomas & Hamilton, 2014).  The 
detailed interviews highlighted the “visible” and “invisible” impacts of lymphoedema and 
the far-reaching implications beyond the diagnoses of cancer or secondary lymphoedema. 
They clearly link the visible and invisible issues and experiences of those with secondary 
lymphoedema to physical and psychological impacts in the domains of appearance, 
function and participation and how that alters a person’s sense-of-self in both the present 
and future. Such emotive description is unable to be collected in quantitative studies.  
Other authors have termed lymphoedema  “a forgotten complication” (McWayne, 2003). 
Some have identified “accidental journeys” where the physical and psychological 
consequences of lymphoedema in everyday life have created “altered normalcy” (p3) 
whereby there may be a perceived loss of control (Meiklejohn et al., 2013).  In these life 
changes, people with lymphoedema report having to adjust.  A greater understanding and 
recognition of the perceived issues of those people specifically with LLL following MM will 
enhance evidence based, patient-centred care.  
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2.3.4 Lymphoedema – Health-related Quality of Life (HRQOL)   
Intrinsically tied with the concepts of physical impact, psychosocial impact and self-efficacy 
are the concepts of Quality of Life (QoL) or Health-Related Quality of Life (HRQoL).   
Whilst outcomes such as disease-free survival (DFS) have been paramount in cancer 
research for many years, the importance of QoL and HRQoL are now more commonly 
acknowledged and recognised in research studies. The concept and dimensions of QoL 
are complex and subjective with many books devoted to the subject (Barofsky, 2012) and 
consequently, no definitive definition has gained acceptance by all working in the field. 
Similarly, HRQoL is defined as: 
“the subjective assessment of the impact of disease and its treatment across the 
physical, psychological, social and somatic domains of functioning and well-being” 
(Revicki et al, 2000).   
QoL and HRQoL have emerged as important outcome measures of optimal medical care, 
particularly for the treatment of chronic conditions of which lymphoedema, and to some 
extent melanoma, have become (Von Korff et al., 1997). The World Health Organisation 
(WHO) in 1993 broadly defines QoL as: 
“an individual’s perception of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, 
standards and concerns It is a broad-ranging concept affected in a complex way by 
the persons’ physical health, psychological state, level of independence, social 
relationships and their relationship to salient features of their environment” 
(Whoqol, 1993) . 
In a literature review conducted in 2005, both qualitative and quantitative studies were 
reviewed regarding HRQoL and lymphoedema (Morgan et al., 2005).  The authors 
documented that low levels of understanding by health professionals regarding 
lymphoedema and inadequate information given to people impacted negatively on 
HRQoL, and that frequency of cellulitis, experiences of pain, poor skin condition and 
lymphoedema in the limb or reduced ambulation correlated with reduced QoL.  A total of 
nineteen studies were reviewed.  Only three of the nineteen related specifically to LLL, 
with two of these focused on filariasis (McPherson & Penzer, 2003) and the remaining 
study on HRQoL in people who had undergone treatment for various gynaecological 
25 
 
cancers (Ryan et al., 2003). As noted in Ryan et al’s study, those women who had 
undergone nodal dissection for their gynaecological cancer (n=82) developed LLL.  
Twelve studies reported on BCRL and the remaining four studies combined data with ULL 
and LLL from various causes (Moffatt et al., 2003; Pereira de Godoy, Braile, de Fatima 
Goday, & Longo, 2002; Sitzia & Sobrido, 1997; Weis & Spray, 2002).  Reports focused on 
how changes in physical symptoms of lymphoedema, such as reduction in leg 
circumferences, volume and pain improved quality of life, rather than specifically on the 
impacts of lymphoedema itself. Certainly, it concurred that people with lymphoedema 
have poorer QoL and HRQoL than those without lymphoedema.  
Cromwell et al. (2015) assessed the impact of both ULL and LLL in a quantitative study 
and found that people with LLL had lower QoL scores on the Functional Assessment of 
Cancer Therapy-Melanoma (FACT-M) than those with ULL.  Additionally, over time, those 
with lymphoedema were reported to have improved coping scores when assessed on a 
coping efficacy questionnaire, suggesting that time was a factor in coming to terms and 
managing the adjustment of lymphoedema. The coping efficacy tool used (Heppner, 
Cooper, Mulholland, & Wei, 2001) was originally validated on women with BCRL so 
consideration should be given as to whether the tool was appropriate for identifying 
coping with LLL or for the male population.   
One study (Gjorup et al., 2017) explored HRQoL in 431 people with recurrence-free 
melanoma  who had experienced stage I-III melanoma. Twenty-five percent of this group 
experienced melanoma-related ULL or LLL and reported significantly worse HRQoL than 
those without lymphoedema in the domains of global health status/quality of life, role and 
social functioning, fatigue, pain and financial difficulties.  Using the EORTC QLQ-C30 and 
the associated breast cancer modules, the FACT-general and the HADS, Gjorup et al. 
(2017) reported that females and younger people with lymphoedema reported more 
negative impacts on social functioning.  Additionally, impaired body image was statistically 
more impaired for women than men.  This study did not include people who had further 
recurrence and it is therefore not surprising the HRQoL scores improved over time. 
The potential burden of treatment modalities and possible effects on QoL (Fu & Rosedale, 
2009; Morgan, Murray, Moffatt, & Honnor, 2012), represents an area that has not been 
well explored. As discussed by Leung and others (2015), aside from focusing only on 
physical clinical effectiveness of treatments, the long-term burdens or side effects of 
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treatments for LLL also require further investigation. Notably, reduction in limb volume 
does not necessarily correlate with QoL improvements (Moffatt et al., 2003; Sitzia & 
Sobrido, 1997) and researchers have indicated that subjective perceptions regarding 
lymphoedema severity may have stronger links than objective measures in terms of QoL 
in BCRL  (Sackey et al., 2015). Research has also established the importance of patient 
self-efficacy in perceiving, coping and managing the risk of, or outcomes of BCRL 
(Alcorso et al., 2016; Sherman & Koelmeyer, 2013; Sherman, Miller, Roussi, & Taylor, 
2015).  Self-efficacy may impact directly on occupational performance and occupational 
therapists may therefore have another opportunity to influence how a person is coping with 
their diagnosis and treatment.  
The physical and psychological implications of lymphoedema have been outlined in 
previous sections but these domains do not exist in isolation.  The impacts of 
lymphoedema on social, psychological and day-to-day functioning have not received as 
much attention in the literature but these impacts are equally significant for those 
experiencing lymphoedema.  Whilst HRQoL questionnaires can give us some information 
of where a person perceives themselves at a point in time, this information may not be 
complete or reflect the implications on occupational performance.  Therefore, the 
importance of exploring responses made on questionnaires cannot be overlooked and 
provide further opportunities for therapists to understand the implications for MM and LLL.  
The specific day-to-day impacts of MM and LLL for an individual, are best noted in 
qualitative studies that explore the richness of individual responses and give voice to 
issues that have been unable to be captured with formal, limited-response QoL 
questionnaires.  
2.3.5 Lymphoedema and Occupational Performance 
Once again, the existing research base reporting that LLL impacts on occupational 
performance across the domains of work, ADL and leisure, comes predominantly from the 
field of gynaecological conditions.  Physical limitations of lymphoedema have been found 
to affect every-day functional tasks such as mobilising or transferring from a bed or chair 
(Brown et al., 2014).  Consequently, activities such as house work and participating in 
social occupations or meeting up with friends has also been identified as being negatively 
affected (Dunberger et al., 2013; Towers et al., 2008). Difficulty putting on clothes or 
compression garments (Beesley et al., 2007; Ryan et al., 2003), reduction in physical 
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tolerance and capacity due to the weight of a limb or the reduction in functional ability has 
been shown to impact on some people’s ability to continue in their regular employment 
(Beesley et al., 2007; Moffatt et al., 2003; Ryan et al., 2003) and factors associated with 
return to work and self-efficacy in ULL have also been explored (Boyages et al., 2016a; 
Islam et al., 2014).  Other researchers confirm that self-care (Lindquist, Enblom, & 
Bergmark, 2015),  and sexual well-being (Winch et al., 2015) are negatively impacted by 
lymphoedema.   One quantitative paper specifically looked at the combination of 
lymphoedema and ADL in the field of MM (Cromwell et al., 2015).  Data were collected 
from 277 men and women with stages I to III melanoma who underwent either a sentinel 
lymph node biopsy (SLNB) or a total lymph node dissection (TLND).   It included a mixture 
of ULL and LLL diagnosis over an 18-month period, with 76 people undergoing TLND.  
Results indicated that lymphoedema, defined as greater than or equal to a ten percent 
change in limb volume, interfered with participation in ADL, particularly with sleep, leisure 
and choice of clothing.  Tan et al. (2014), reported pain and physical limitations following 
treatments that impacted negatively on work, leisure roles and ADL’s with resulting impact 
on social and vocational roles.  Their study included people with stage III melanoma 
across the body, so it is not possible to extrapolate whether there were differences 
between those with lymphoedema of differing body parts.   
Perceived losses in the areas of function, appearance, leisure pursuits, social supports 
and ADL’s that were once taken for granted constitute the need to plan for a future where 
these issues must be factored into their daily life (Thomas & Hamilton, 2014).  Research 
suggests that LLL does impact on occupational performance, however data pertaining 
specifically to LLL for stage III MM is lacking.  
2.4 LYMPHOEDEMA TREATMENT  
Lymphoedema cannot be cured and therefore treatment is focused on managing 
symptoms, preserving and maximising function, minimising infection and enhancing 
quality of life (International Lymphoedema Framework, 2006). An intensive treatment 
phase of 2-4 weeks followed by a maintenance phase that includes lifelong follow-up is 
recommended. Traditionally, lymphatic drainage, compression bandaging and garments, 
skin care and exercise were the pillars of complex decongestive therapy (CDT) during the 
intensive treatment phase (Foldi, Foldi, & Clodius, 1989) followed by a life-long 
maintenance phase.   Variations in terminology now exist for the initial intensive phase 
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and include complex decongestive physiotherapy (CDP) or complex physiotherapy (CPT), 
decongestive lymphatic therapy (DLT) or complex decongestive lymphoedema therapy 
(CDLT). Furthermore, other treatment modalities have been added to therapeutic regimes 
making it even more difficult to determine which modality is most effective. 
Lymphatic massage conducted by a trained lymphoedema therapist and termed manual 
lymphatic drainage (MLD), or simple /self-lymphatic drainage (SLD) when conducted by 
the person with lymphoedema, have been assessed in various research studies (McNeely 
et al., 2011; Rasmussen, Kwon, Sevick-Muraca, & Cormier, 2012; Rodrick et al., 2014; 
Sitzia, Sobrido, & Harlow, 2002; Tan et al., 2011; Williams, Vadgama, Franks, & Mortimer, 
2002) with mixed results.  Multi-layer bandaging (MLB) and compression garments have 
also been assessed by many researchers (Badger, Peacock, & Mortimer, 2000; Devoogdt 
et al., 2010; McNeely et al., 2011; Moseley, Carati, & Piller, 2007; Oremus, Dayes, 
Walker, & Raina, 2012; Preston et al., 2004)  along with recommendations about skin and 
nail care (International Lymphoedema Framework, 2006) and physical exercise (Kwan et 
al., 2011; Oremus et al., 2012; Poage et al., 2008; Shaitelman et al., 2015; Singh, Disipio, 
Peake, & Hayes, 2016). It has not been possible to determine the modality that is most 
effective during treatment.  
Most systematic reviews focus predominantly on ULL despite the significant occurrence of 
LLL (Devoogdt et al., 2010; Disipio et al., 2013; Kligman, Wong, Johnston, & Laetsch, 
2004; Leung et al., 2015; Paramanandam & Roberts, 2014; Poage et al., 2008; Preston et 
al., 2004) and a significant proportion of research has been focused on determining the 
most effective component of lymphoedema treatment.  Researchers have attempted to 
investigate the contribution of additional therapeutic modalities such as pneumatic 
compression pumps (Muluk, Hirsch, & Taffe, 2013; Shao, Qi, Zhou, & Zhong, 2014), 
complementary and alternative  therapies (Finnane et al., 2011; Loudon et al., 2014), low 
level laser therapy (Lau & Cheing, 2009; Omar et al., 2012; Smoot et al., 2015), kinesio-
taping, (Rodrick et al., 2014), shock wave therapy (Bae & Kim, 2013)  and variations of 
compression bandages and wraps (Devoogdt et al., 2010; McNeely et al., 2011; Moseley 
et al., 2007; Oremus et al., 2012; Preston et al., 2004). However, further research is 
required as findings are inconclusive and currently clinical practice utilises a mixture of 
modalities.  
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In summary, whilst CDT is considered by experts in the field and lymphoedema 
associations as current best practice, systematic reviews have been conducted regarding 
physical treatment modalities and conclusive evidence is lacking as to which components 
of physical treatment are most effective for managing lymphoedema symptoms (Moseley 
et al., 2007; Poage et al., 2008; Preston et al., 2004; Rodrick et al., 2014; Shaitelman et 
al., 2015).  Efficacy of individual treatment modalities remains unclear and currently expert 
opinion continues to support the use of lymphoedema treatment programs that include a 
combination of conservative treatment modalities.  
2.5 LYMPHOEDEMA PREVENTION  
Evidence regarding LLL prevention programs is lacking (Sawan et al., 2009; Shaitelman 
et al., 2015; Stuiver et al., 2013). Studies evaluating prevention programs have small 
numbers and involve participants with varying diagnoses making it very difficult to cite any 
significant evidence base. Recommendations for LLL prospective surveillance and early 
intervention strategies exist (Lloyd, 2013; Lloyd et al., 2014) with more research available 
in the field of BCRL (Box, Reul-Hirche, Bullock-Saxton, & Furnival, 2002; Lacomba, 2010; 
Singh, De Vera, & Campbell, 2013; Stout et al., 2012b). Historically, lymphoedema 
treatments commenced when an individual developed LLL and was referred by their 
medical specialist.  Not surprisingly, it has been recognised that early intervention in 
lymphoedema improves treatment outcome (Armer et al., 2013; International 
Lymphoedema Framework, 2006; Kerchner, Fleischer, & Yosipovitch, 2008) and that a 
persons’ level of knowledge and belief,  or self-efficacy in being able to control 
lymphoedema contributes to improved risk reduction factors (Lindquist et al., 2015; 
Sherman & Koelmeyer, 2013).  Whilst surveillance models promoting early identification 
of LLL have been encouraged (Binkley et al., 2012; Lloyd, 2013; Singh et al., 2013), few 
studies have attempted to explore the impact of proactive preventative programs 
regarding burden of care and occupational performance for individuals.   
Traditionally, therapists have adopted conservative risk reduction approaches that have 
been endorsed by peak bodies (Lymphoedema Framework; National Lymphology 
Network; Australasian Lymphology Association) and followed best practice guidelines that 
include maintenance of a healthy BMI  (Ridner, Dietrich, Stewart, & Armer, 2011; Shaw, 
Mortimer, & Judd, 2007),  avoidance of extremes of heat (International Lymphoedema 
Framework, 2006) and avoidance of limb trauma such as needle stick injury/venepuncture 
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or limb constriction (Clark et al., 2005; Dell & Doll, 2006; International Lymphoedema 
Framework, 2006).  Radiation has been deemed a further risk factor (Burmeister, 
Smithers, & Davis, 2002; Hinrichs et al., 2004; International Lymphoedema Framework, 
2006; Warren et al., 2014), as well as taxane-based chemotherapies (Cariati et al., 2015; 
Kilbreath et al., 2016), infection (Clark et al., 2005; International Lymphoedema 
Framework, 2006), extent of surgery (Goldberg, Wiechmann, & Riedel, 2010; Kilbreath et 
al., 2016), and even flying (Casley-Smith, 1996). Historically “over-exercising” was once 
considered potentially problematic for people at risk of lymphoedema but the 
psychological and health effects of exercise may outweigh any remaining concern that 
might exist.  A systematic review (Cemal et al., 2011) documented that level 1 and 2 
scientific evidence supported the recommendation of maintaining a healthy body weight 
and being involved in supervised exercise programs however high-level evidence is 
lacking to support the recommendations to avoid limb constriction, elevation, extremes in 
temperature or the issues when flying.  
Both McLaughlin (2012) and Cemel et al. (2011) report on studies that support and refute 
precautionary or risk reducing factors for lymphoedema. They acknowledge that much of 
the advice is based on expert opinion and sound physiological principles but are unable to 
adequately report on good scientific evidence that any other factors contribute to the 
development or worsening of lymphoedema. Other authors recognise that  factors such 
as coping-style, anxiety and perceived support networks are important with respect to 
ongoing self-care of lymphoedema (Cohen, Payne, & Tunkel, 2001) and that the construct 
of self-efficacy was important to keep people engaged in their ongoing care (Lindquist et 
al., 2015; Sherman & Koelmeyer, 2013). It has been suggested that the experience of 
chronic illness disrupts one’s sense-of-self and identity (Bury, 1992; Charmaz, 1983).  
Empowerment is a concept that some authors feel is an extension of self-efficacy 
(Aujoulat, Marcolongo, Bonadiman, & Deccache, 2008) where people value knowledge 
about their conditions as well as assigning a meaning to their chronic condition so they 
may perceive their altered lives as meaningful.  With LLL and stage III MM now 
considered chronic diseases, consideration should be directed to how health 
professionals can assist people in maximising self-efficacy or empowerment. 
A feasibility study with fourteen women following surgery for vulval cancer in the United 
Kingdom, explored the acceptability of wearing preventative graduated compression 
garments (15-20mmHg) over a 6-month period.  The researchers suggested that the 
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practice of wearing compression garments caused no apparent harm, that quality of life as 
scored on the Nottingham Health Profile (NHP-1) was no different between the standard 
supportive care group or the group that received standard supportive care and wore 
prophylactic compression garments (Sawan et al., 2009).  Additional results demonstrated 
improvement in symptoms reported, and on clinical examination the group wearing 
garments had less increase in leg volume than those in the control group, but this failed to 
reach the statistical significance set by the research team (Sawan et al., 2009).  However, 
if Burmeister et al. (2002) were correct and maximal LLL is reached between 14-17 
months, these figures might be inconsequential, and the study should have continued 
measures and monitoring for a longer period to determine if this outcome altered over a 
longer duration. 
In contrast to this finding, a prospective randomised controlled trial (RCT) in the 
Netherlands assessed whether wearing graduated compression garments (23-32mmHg) 
for 6-months had an impact on LLL prevalence (Stuiver et al., 2013). A total of 80 people 
including 45 with melanoma and 35 with urogenital tumours who had undergone inguinal 
lymph node dissection were included in the study. A 14% reduction of LLL was achieved 
in the intervention group however, researchers had set their target to 30% reduction to 
reach significance.  Therefore, the study did not reach statistical significance and they 
concluded that the use of garments did not statistically reduce the occurrence of the 
condition. In general terms, the data suggested that approximately seven people would 
need to wear compression garments to prevent one case of LLL.  Using the definition of 
LLL the authors had proposed, 80% of people with melanoma and 57% of people with 
urogenital tract cancers developed LLL during the study.  The prevalence figures 
documented in this prospective study for LLL prevention following nodal dissection for 
melanoma were considerably higher than figures reported by other authors.  Overall, a 
cumulative incidence of 69% of people in the study developed LLL, which again, is higher 
than figures listed in the melanoma or gynaecological literature prior to this. As outlined 
earlier in this thesis, issues of retrospective versus prospective reporting, differing 
definitions and methods of measurement of LLL may be confounding variables in such 
analysis.  The authors concluded that further investigations were required, and that 
education, surveillance and early detection and intervention might be a more economical 
way forward.   Surveillance models for ULL and LLL have been supported by other 
researchers (Armer et al., 2013; Binkley et al., 2012; Boccardo et al., 2009; Lloyd, 2013; 
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Ostby et al., 2014; Stout et al., 2012a) but are not common practice in clinical settings for 
LLL now. 
There is currently no conclusive evidence whether conducting preventative treatment 
practices are effective in preventing or minimising LLL.  Further, the impacts on 
occupational performance during surveillance for, or preventative treatment of LLL have 
not been investigated and individuals have not been engaged in determining whether 
potential benefits of prevention or treatment outweighs potential burden.  
2.6 THE ROLE OF OCCUPATIONAL THERAPY IN THE PREVENTION AND 
TREATMENT OF LYMPHOEDEMA.   
As an occupational therapist specialising in lymphoedema treatment, expertise needs to 
extend beyond the physical components of pressure bandaging, conducting lymphatic 
drainage or detailed knowledge of the condition and surgery that preceded the swelling. 
The act of reducing the size of a swollen limb does not necessarily equate to returning to 
the richness of engaging in activities that have personal and symbolic meaning.  
Occupational therapists support occupational performance and well-being.  They 
recognise that when a condition or situation impacts on a person’s engagement in 
occupation, there are corresponding changes in their identity, well-being and participation 
(Christiansen et al., 2015). It could be suggested that the lens through which occupational 
therapists’ view health, well-being and occupation is wider than that of medical science.  
The interaction of person, environment and occupation is central to occupational therapy 
practice, as indicated in the Person-Environment-Occupation (PEO) model (Law, 1996).  
Throughout history in health, biomedical models have predominated.  These bio-medical 
models have also predominated in lymphoedema treatment, with most attention given to 
specific physical and measurable outcomes with individuals seen as passive recipients of 
care from expert health professionals.  
 2.7 OCCUPATION AND OCCUPATIONAL PERFORMANCE 
“Occupations are purposeful and meaningful daily activities that fill a person's time and 
are typically categorized as self-care, work, play or leisure, and rest” (AOTA., 2002; Baum 
& Edwards, 1995; Meyer, 1922).  Occupation is as basic as doing what one needs and 
wants to do on a day-to-day basis. Occupational performance has been defined as “the 
doing of meaningful activities, tasks, and roles through complex interactions between the 
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person and environment” (Christiansen, Baum & Bass, 2015; p 40) and is a common 
concept in all occupational therapy models. The Person-Environment-Occupation (PEO) 
model (Law et al., 2005) is often used in occupational therapy and acknowledges the 
transactional nature of health and well-being, where a misfit between person, environment 
and occupation may contribute to occupational disruption resulting in negative emotions 
such as sadness, fear, anxiety, grief, boredom or isolation . By looking through the lens of 
this model, internal and external changes (e.g. changes in physical, social, societal, 
institutional, political, cultural and temporal domains), influences the context (Turpin & 
Iwama, 2011) of how people perceive themselves.  Therefore, these intrinsic and extrinsic 
factors) within and beyond the person need to be recognised and understood to maximise 
satisfaction, function and performance in a person’s life.  Being confident, capable and 
happy to participate in all tasks that make it possible to fulfil developmentally and culturally 
appropriate occupational roles is at the heart of occupational therapy. Occupational 
therapists, regardless of their specialty, recognise that patient-therapist interaction is 
important and the complex interplay of PEO environment, occupation and person 
including.  The Model of Human Occupation (MOHO) would term people’s perception of 
themselves as “occupational identity” and recognises that “occupational competence” can 
be achieved when a person can fulfil the expectations of their roles and values (Kielhofner, 
2009).  
Occupational therapists recognise the complex, transactional nature of person, occupation 
and environment and are therefore well placed to address cancer-related limitations and 
their impacts, and to positively impact a person’s overall QoL (Pergolotti et al., 2016). 
Therefore, although a lymphoedema trained occupational therapist may be contacted 
initially to deal with the physical consequences of a person’s lymphoedematous leg, the 
intervention, therapy and care provided goes far beyond reducing the size of the person’s 
limb.  They may need to assess, manage and treat psychosocial and occupational needs, 
consider the context within which the individual lives, acknowledge individual responses 
and mechanisms of coping, make relevant referrals to other providers outside their scope 
of practice, be mindful of communication issues and provide an environment where a 
person receiving treatment can safely and confidently receive and engage in care.  
Occupational therapy approaches aim to be collaborative and person-centered, whilst 
engaging people as active participants in their self-management.  This  is congruent with 
positive outcomes in cancer care (Gast, Allen, Ruddy, & Haddad, 2017) as well as health 
care in general (Thorne et al., 2014). Therefore, lymphoedema trained occupational 
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therapists are well placed to assess, manage, treat and provide opportunities that support 
self-efficacy and empowerment of people who have been diagnosed with stage III MM 
and are at risk of, or have developed LLL.  
2.8 SUMMARY 
Stage III MM and the treatments required to preserve life have profound impacts on 
individuals and their families. This fear and risk of recurrence is high and for those who do 
progress to “survivorship”, ongoing psychosocial burdens remain.  Lymphoedema is a 
chronic condition and impacts people’s lives in every domain, and the optimal treatment 
protocols remain controversial (Javid & Anderson, 2013; Rodrick et al., 2014; Shaitelman 
et al., 2015).  Therefore, prevention is an important goal.  The overall treatment of 
lymphoedema itself is time-consuming, intensive, unrelenting and burdensome and there 
does not appear to be any studies that have been able to extract to what extent the 
burden is related to the condition itself or the treatment required to manage it.  Is it even 
possible to separate the two components? 
Of specific interest in this thesis, are the perceived experiences and needs of men and 
women who have undergone surgery for stage III MM and are at risk of or have 
developed LLL. Globally, evidence for the effective prevention of lymphoedema has yet to 
be established and burden of care for preventative programs has not been investigated. 
Surveillance programs have been recommended by some experts in the field but are yet 
to be supported with evidence.  To ensure best practice in the provision of occupational 
therapy to this group of people and truly minimise negative impacts on occupational 
performance, we first need to understand these impacts, specific concerns, and the 
implications for current service provision.  The author is not aware of any studies that 
have explored these issues from the perspective of people receiving care.   
Therefore, this thesis aims to explore the experiences, occupational performance impacts 
and needs of people who are at risk of or have developed lymphoedema following inguinal 
(groin) or ilio-inguinal (groin/pelvic) node dissection for stage III metastatic melanoma. 
This will be achieved by addressing the following research questions: 
1) What are the experiences, impacts and needs of people with stage III MM following 
surgery to the groin/pelvis? 
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2) What are the experiences of monitoring and proactive, preventative approaches for 
LLL following surgery for stage III MM?  
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CHAPTER 3: METHODOLOGY 
This study seeks to understand and explore the experiences, occupational performance 
impacts and needs of people who are at risk of or have developed LLL following inguinal 
or ilio-inguinal node dissection for stage III MM. Chapter 3 presents the methodology 
underpinning the research, including justification for the use of an interpretive description 
(ID) approach, and the methods taken to ensure rigour was achieved within the study. 
3.1 RESEARCH DESIGN FRAMEWORK 
3.1.1 Interpretive Description 
An interpretive description (ID) qualitative research methodology (Thorne, Kirkham, & 
MacDonald Emes, 1997) underpinned this study. In ID, which is grounded in the 
constructivist paradigm, the researcher endeavours to make sense of and convey the 
meanings that others have attributed to their experiences whilst considering both shared 
and individual variations of experiences. Its assumptions reflect those found in naturalistic 
inquiry (Thorne, 2008). Emerging from the nursing profession, the goal of ID is to develop 
practice knowledge that can inform and influence clinical practice and is therefore ideal for 
addressing the aim of this thesis.  Further, subjective and experiential knowledge of the 
practitioner-researcher is valued, with this prior knowledge often being considered the 
starting point for research in ID.  This methodology recognises that the researcher cannot 
“un-know” or fail to be influenced by their knowledge and experiences in their field of 
expertise.  Indeed the “knower and known are inseparable” (Thorne et al., 2004, p.5).   
This relatively new qualitative method emerged from the realisation that traditional 
qualitative methods, such as phenomenology, ethnography and grounded theory were 
developed from disciplines such as philosophy/psychology, anthropology and sociology 
respectively and that these areas were not totally congruent with questions arising in 
applied health care.  Subsequently qualitative researchers had become concerned with 
the issues of “methodological slurring” (Baker, Wuest, & Stern, 1992; Morse, 1994) that 
had occurred as a consequence of mixing traditional methodological genres in order to 
meet the needs of the applied health disciplines.  Rather than jeopardise methodological 
credibility and rigour, ID was developed (Thorne et al., 1997).   
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3.1.2 Interpretive Description – Framework and Context. 
ID is a methodology designed to explore the experiences of people with health conditions 
(Thorne, 2008) because it seeks to comprehend both shared and individual expressions of 
variance (Thorne, 2008; Thorne et al., 1997; Thorne, Reimer Kirkham, & O'Flynn-Magee, 
2004), and aims to derive knowledge that has direct practice implications for clinicians in 
the field.  Rather than follow a set of unbreakable rules, ID processes require logical, 
practical framework or “scaffolding” in conducting qualitative research. (Thorne, 2008). The 
framework enables a variety of data collection and analytic strategies to be used in 
accordance with careful, transparent reasoning throughout the research process (Thorne, 
2008). Understanding the gaps in evidence (through review of the literature), as well as the 
researchers’ personal and professional ontological and epistemological stance are 
deemed important throughout the research process using ID.  This awareness and 
recognition will shape the decision-making processes from question formulation, choice of 
methodological tools and analysis through to presentation of findings. Beginning with the 
research question that has been shaped by the researchers’ pre-existing knowledge and 
immersion in the existing literature, the quality of the study relies on congruence between 
the question and the qualitative method used to explore it. Thorne would consider an initial 
component of “theoretical scaffolding” as the researcher recognising who they are, what 
they represent, what they are trying to accomplish and how their ontological and 
epistemological stance alters the lens through which the data will be gathered and 
analysed. 
The context in which the research question is also generated also needs to be considered 
as it also shapes the lens through which data will be gathered and analysed.  In this 
study, the views of the researcher who works within an acute hospital setting as a 
lymphoedema trained occupational therapist need to be acknowledged. Occupational 
therapy is a profession which applies theory and clinical knowledge to maximise human 
health and well-being whilst remaining client-centred and viewing the person as an 
occupational being (Wilcock, 1998).  Occupational therapy is a pragmatic discipline that 
has long seen the importance of balancing “art and science” (Kielhofner, 2009).  This dual 
perspective has also seen the profession of occupational therapy being termed a “two-
body practice” (Mattingly & Fleming, 1994, p. 37) as clinicians deal with physical and the 
lived experiences of the conditions in daily life.  This is congruent with Thorne’s (2008) 
methodological framework of ID as it tries to find commonalities and differences in the 
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lived experiences of people dealing with illness. Whilst Thorne’s ontological and 
epistemological stance emerges from the profession of nursing, the field of occupational 
therapy has similarities with what she summarises as the “nursing praxis orientation”.  
Thorne (2008, p.25 - 26) states the in the world of nursing “the care of any individual 
patient involves examination of the interplay between objective and subjective information 
- working within a dialectic of practice and knowledge”. Similarly, occupational therapists 
in clinical practice have experienced conflict in the delivery of services, being pulled 
between science-based models and the art of practice, where science could be 
considered tangible proof and art reflects the symbolism and people’s perception and 
meaning of this  (Kielhofner, 2009; Turpin, 2007). It has been argued that in order to 
deliver optimal care to people, the blending of “art and science” is required and involves 
integrating scientific evidence and EBP with the human variability that is inherent in 
individuals (Kielhofner, 2009; Powers-Dirette, 2016; Turpin, 2007).     
3.1.3 Locating the Researcher’s Position in the Study 
In addition to a literature review and considering the context in which the research will be 
conducted, an additional component  of “scaffolding” or structuring the study is the 
researcher locating themselves and their discipline, within it (Thorne, 2008). This 
theoretical structure involves acknowledging the researcher’s loyalties regarding their 
professional discipline and the personal experiences prior to commencing the study and 
ultimately seeks to understand their ontological and epistemological stance.  As the 
researcher, acknowledgement is required that my life has been shaped by many factors 
including my values and beliefs, my cultural environment, my professional training and 
experiences and what I have seen as both a clinician and human being in everyday life. 
The lens through which I view my personal and professional life remains important in 
considering how this qualitative research project is analysed and presented and is 
therefore presented here. 
I am a lymphoedema trained occupational therapist who has worked in this specialty field 
for over 13 years.  As a pragmatic, experienced clinician, I believe that factors beyond the 
biomedical domains are valuable and should be equally considered as a fundamental 
component of care for people with stage III MM, who are at high risk of LLL following 
surgery.  Specifically, exploring the experiences, occupational performance impacts and 
needs of these people may inform current gaps in knowledge and inform clinical practice 
in this field.  The ID design is built upon what is already known from the literature and 
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what gaps in knowledge appear evident (Thorne, 2008). Therefore, knowledge of the 
existing literature regarding melanoma, LLL and lymphoedema prevention is paramount 
and was presented in Chapter 2.    
Personally, I have grown up in a community minded family, with great emphasis on the 
importance of trying to understand other’s perspectives and understanding that every 
person is fighting their own battles that might not be visible to others.  I have watched and 
witnessed loved ones, friends and people I treat struggle with health conditions including 
cancer and have seen both the positive and negative impacts that are associated with the 
physical, psychological and occupational performance burdens that come with such 
diagnoses and treatment.   
Professionally, my early years working as an occupational therapist during a time where 
contemporary occupational therapy had been challenged with a biomedical focus with 
quantitative outcomes taking precedence and consequently the richness that I perceived 
in occupational therapy had been pushed aside for some time. This have invariably 
shaped my beliefs, assumptions and perspectives.  Patton (2015, p.122) suggests that 
the researcher acknowledge their ontological assumptions and where they stand on the 
continuum in their view regarding the nature of “reality”. There are the “realists” who 
believe in absolute objectivity and consider reality to be independent of knowledge and 
cognitive approach; or the “relativists” who believe that reality is socially constructed and 
that the researcher is a player in constructing that reality (Denzin & Lincoln, 2011).  As the 
researcher in this study I believe I sit somewhere between these dichotomous theories.  
ID’s methodological framework attempts to “straddle the chasm between objective 
neutrality and abject theorizing” (Thorne, 2008 pg. 26) and therefore, this study is more 
aligned with a moderate relativist position  (Schwandt, 2000) that acknowledges both the 
rational and social aspects of knowledge.  The group I am researching are united by a 
shared diagnosis, procedure and process. However, I remain open to the fact that their 
experiences of these processes and procedures may be perceived very differently.  
3.2 ETHICAL CONSIDERATIONS 
Ethical approvals for this study were approved by the School of Health and 
Rehabilitation Sciences Research and Postgraduate Studies Committee at The 
University of Queensland, and the Mater Research Institute (Appendix A).   In addition 
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to this, appropriate professional and moral conduct was adhered to and close liaison 
and involvement with the supervisory team was conducted throughout the process  
Eligible participants were approached by research staff and provided the opportunity to 
ask questions or seek clarification about the study prior to providing written consent to 
participate.  Participants were provided with an information sheet outlining the purpose of 
the study, research procedures (including confidentiality and anonymity, and their right to 
withdraw from the study) and participant expectations.  They then signed an informed 
consent form (Appendix B). In the event of possible emotional distress during 
interviewing, the researcher could offer support through referral to another source 
(psychosocial occupational therapist, psychologist) or through de-briefing at the 
cessation of the interview.     
3.3 PARTICIPANTS 
3.3.1 Context and setting 
Participants in this study were recruited over a two-year period between 2015 and 2016 
at a major tertiary hospital in Brisbane, Queensland.  People with a diagnosis of stage 
III MM of the groin and/or pelvis undergo inguinal or ilioinguinal node surgery and 
remain in hospital for an average of 5 post-operative days before returning home.  
They are then seen routinely at 3-month intervals for 2-years for follow-up, monitoring 
for recurrence of MM by the treating surgeon and research nurse and for lymphoedema 
specific measures by lymphoedema therapists and the principal investigator (PI) of this 
study. 
Participants in this study were participants in a larger, randomised control trial (RCT) 
looking to test the effect of implementing a proactive, preventative treatment for 
lymphoedema development for minimising the risk of LLL following surgery.  In the 
RCT, participants were randomly allocated to a preventative treatment group or control 
group.  Those in the preventative treatment group were required to attend clinics for 
monitoring at 3-monthly intervals.  They were required to wear a 20-30mmHg thigh 
high compression garment on the operative limb and 17mmHg bike shorts for 16-hours 
per day and conduct daily simple lymphatic drainage (SLD) for 6-months following 
drain removal.  Those in the control group attended the clinics with the same frequency 
and had all the same monitoring measures performed but did not wear garments or do 
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daily massage at home.  If any of the participants within either of the RCT groups were 
diagnosed with recurrence of melanoma or developed LLL, treatment was provided in 
accordance with ethical care 
3.3.2 Inclusion and Exclusion Criteria 
Inclusion criteria for participants in the RCT and this ID study were as follows:   
• 18 years or over, 
• undergone surgery for confirmed stage III MM to the groin/pelvis, 
• no pre-existing lymphoedema prior to surgery  
• cognitively intact 
• access to an interpreter or able to speak English.   
Exclusion criteria relating to the ID study included the following: 
• pre-existing lymphoedema prior to surgery 
• bilateral groin dissection for MM 
3.3.3 Recruitment and Sampling  
Once eligibility was established, people were approached to consider entry to the 
qualitative study at approximately 5-6 months following the removal of their surgical 
drain. A participant information and consent form (PICF Qualitative – V4) was provided 
(See Appendix B) and any questions were answered by the researcher.  If the patient 
agreed to participate, the consent form was signed and returned to the PI.    
This ID study used purposive and convenience sampling.  A purposive sample is 
defined as one where the cases studied are selected because they provide 
“information rich” cases for enquiry into and understanding a phenomenon in depth 
(Patton, 2015 pg. 46). Due to recruitment of the participants occurring in a single centre 
convenience sampling was also utilised.  Patton (2015) stated that homogeneous 
samples are useful in describing a common experience and that it is within this shared 
experience that the researcher discovers the essence or commonalities and variations 
of parent’s experiences. Thorne (2008) however highlights the importance of seeking 
as many perspectives as possible.  Collecting information and different perspectives 
from people at various stages of functional and occupational performance stages of life 
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may help to gather alternative perspectives and this complements Thorne’s (2008) 
methodology in seeking “outliers”. Therefore, whilst participants were homogenous in 
their diagnosis, time since diagnosis and operative status, maximum variation was 
sought in terms of gender, age, marital/relationship status, education, 
occupational/employment status, and lymphoedema status since their operation. This 
qualitative study sampled participants (n=11) from both groups of the RCT and 
included men (n= 5) and woman (n=6) with stage III MM of the groin/pelvis. 
3.4 DATA COLLECTION AND ANALYSIS 
3.4.1. Data Collection 
The primary source of data collection was semi-structured interviews with data 
collection and analysis occurring concurrently.  Following verbal and written consent, 
individuals were offered a variety of times to attend an interview, which occurred in a 
quiet, relaxation room in the occupational therapy outpatient area. Appendix C outlines 
the basic list of interview questions. A second interview was undertaken with 
participants approximately 3 to 6-months after the first interview which assisted in 
clarifying concepts or exploring data further.  At all stages, the physical and mental 
health of all participants remained the highest priority in accordance with both ethical 
and moral principles.  The interviews were audiotaped, typed verbatim and listened to 
several times to document further important facts about the interview.  Field notes, 
diary entries and personal reflections from the researcher as memos were also used to 
capture pertinent data. Basic demographic data were collected including age, gender, 
occupational/employment status, relationship status, lymphoedema status and living 
situation.  Basic medical data were also documented and included co-morbidities, post-
operative complications (seroma, wound dehiscence, haematoma), and if the 
participant had adjunct therapy.  Additionally, place of residence was noted to 
determine the mix of metropolitan versus non-metropolitan participants.  
Characteristics of this group will be discussed in Chapter 4. 
At the time of data collection, all people that had provided consent to be interviewed were 
attending the hospital for outpatient follow-up, surveillance for, or treatment of LLL as a 
consequence of their surgery from stage III MM and were still under the care of their 
surgeon at the same hospital. The researcher had known each participant for a minimum 
of 6-months and carried out the interviews. Much consideration was given to the 
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implications of the researcher conducting the interviews.  It was felt that the existing 
rapport, therapeutic relationship and previous knowledge of each patient would promote 
more honest and transparent responses during interviewing.  Conversely however, this 
may have been a barrier for some people in providing honest answers.  Given the author’s 
dual relationship with these individuals, as a clinician and researcher, the understanding 
of these roles will be acknowledged and addressed including the researchers’ set of 
beliefs and issues such as balance of power, choice of framework, data obtained and 
interpretation of the data (Carlson, 2003).  The implications or impact of each role are 
discussed in more detail in a reflexivity statement in section 3.4 and in chapter 5, the 
discussion chapter. 
3.4.2 Data Analysis 
The interview transcripts were analysed using constant comparative analysis (Creswell, 
2013).  Using this inductive analytic approach, codes were formulated and used to 
formalise identification of themes and create a cohesive narrative that could reasonably 
provide a platform for improved clinical care with this group of people).  Knowledge was 
inductively generated from within the data and developed within the context of that data.  
Journal entries and memos were used to compliment this process and involvement of 
peers and experts in the field also occurred.  The issues of rigor and trustworthiness are 
discussed in section 3.4.   
The processes described by Thorne (2008) about data analysis in ID are outlined below.  
The relevant steps that the researcher took to remain true to the ID methodology are 
discussed in here. 
1. Developing a sense of the information presented: In this study, the researcher was 
responsible for conducting all interviews and was immersed in the data by listening, 
transcribing and reading through all the interview transcripts multiple times prior to 
and throughout coding. A second researcher (SB) also read the transcripts 
independently prior to and during coding.  
 
2. Coding, categorising and reflective memos: Thorne et al (2004) recommend using 
very broad coding schemes in the infancy of data collection.  Critically evaluating 
coding at all stages of analysis and including other relevant categories or reflective 
memos to assist in reflection and hypothesising assisted in the ongoing groupings 
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or patterns in the broad conceptual framework.  Thorne recommends moving from 
“pieces to patterns” (Thorne, 2008, pg. 142) and ensuring that time is allocated to 
allow the memorable and “expected” responses to be recognised. As recommend 
by Thorne (2008, p 129) a “quotable quotes” file was created during this study to 
ensure that emotive phrases that may have appealed to the researcher’s immediate 
attention were recorded but that due care was taken to handle them carefully in 
terms of scientific credibility.  Simultaneously, attempting to acknowledge 
disciplinary context, personality and experience, as well as curiosities is 
encouraged by Thorne. In this study, reflective memorandum writing occurred 
during, immediately after and during transcript reading. Comments regarding the 
researcher’s thoughts, questions, perceived strengths and weaknesses regarding 
interviews and overall feelings about the interviews were documented in a journal.  
Regular meetings and discussion with supervisors occurred and prompted ongoing 
shaping and review of the coding and analysis of transcript data.   
 
3. Moving from patterns to relationships: This is the process of looking at data and 
assigning meaning.  In this study, inductive processes were used in data collection 
and analysis.  The importance of “knowing your data” and being able to shift 
between individual cases to the data set in its entirety; identifying similarities and 
outliers is important in ID.  Each piece of data was compared with others to seek 
similarities and differences. Two researchers coded and assigned meanings 
independently of each other and where agreement was unable to be reached, a 
third researcher was consulted to reach a consensus. This fostered pattern 
formation and uncovered both commonalities and differences which was helpful in 
generating a narrative that could go on to inform clinicians working in the field. 
 
4. Constant critical review and analysis of the data:   Thorne (2008, p. 155-157) 
highlights the importance of trying to avoid hazards such as premature closure, over 
or under-representing importance of frequency or “becoming one with the data”. 
Therefore, intensive memo writing, journal entries of analytic thinking, reflection on 
how personal and professional experiences may impact, and engaging experts to 
assist in keeping representations honest was conducted. As stated by Thorne 
(2008) on pg. 88, “in the research world we must assume that every voice that we 
will encounter is trying to expand knowledge about a human experience and will 
have an explicit interest or bias to bring to our attention”. In this study, it was 
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therefore important for the researcher to acknowledge such hazards during written 
and cognitive reflection.  On occasion, this resulted in needing to step away from 
the data and engage others for professional feedback and expert opinion.   
 
5. Confirming linkages, returning to participants and testing relationships:  As 
suggested by Thorne on page 158 (Thorne, 2008), the importance of stepping back 
from the data and asking questions such as “What am I seeing?” and “Why am I 
seeing that?” were important and therefore, repeat interviews were conducted with 
most participants.  Constant comparative analysis (Glaser & Strauss, 1967) is an 
approach that has been borrowed from Grounded Theory (Thorne, 20008, pg. 151) 
for this research method.  In ID, repeat interviews are preferred over traditional 
member checking, to confirm, clarify and elaborate on essential relationships that 
are suspected within the overall data set.  Ideas that might be emerging should link 
back to the original scaffolding that helped formulate the study question originally.  
Member checking was done additionally in this study as it was felt that participants 
were looking for opportunities to impart their message.  Therefore, a summary of 
the main ideas in their initial interview were provided for them to comment on and 
they then had opportunities at a second interview to elaborate further. 
 
6. Looking for missing pieces and engaging critics:  The importance of asking “What 
might I not be seeing?” and seeking expert opinion through peers or literature 
review are recommended in ID to ensure your findings do not ignore the inevitable 
variation that exists within humanity. In this study, attempting to have maximal 
variation within the participant group was important but recognising that the data 
collected will not possibly reflect all possible opinions and experiences was 
important.  Identifying “outliers” whose experiences might not fit categorically with 
most responses was also important during the study.  Additionally, having 
supervisors or experts to engage with during the process was essential to promote 
academic debate, often deepening insight and perspectives in the process.  This 
was ongoing throughout the course of the study. 
 
7. Conceptualising findings: The analytic process of moving from early exploration 
through to meaningful conceptual findings involves cognitive processes of data 
analysis, including comprehending, synthesising, theorising and re-contextualising 
(Morse, 1994).  Thorne (2008, p. 169) states the importance of generating 
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knowledge that is clinically relevant and that “the research report makes visible and 
accessible the clinical wisdom of a passionate and thoughtful expert practitioner for 
whom a similar understanding had been acquired through extensive pattern 
recognition and reflective practice observations”.  
 
8. Disseminating the findings: results and clinical phenomenon of the ID study need to 
be distributed to practitioners working in the field. The report will give voice to the 
participants, reflect findings regarding the research question, be transparent in 
terms of an audit trail, and refer to the implications to clinical practice. Therefore, 
results from this study will be disseminated in appropriate journals, professional 
conferences and interest groups.   
3.5 CREDIBILITY  
In qualitative research, establishing credibility using rigorous methods is critical to ensure 
the data collection and data analysis and reported findings are true to the experiences of 
participants being studied (Curtin & Fossey, 2007; Patton, 2015; Stanley & Nayar, 2014). 
Such credibility is sought to ensure those who read or encounter the research can judge 
the truth-value or merit of the research (Patton, 2015). To assess credibility, one would 
focus on the data quality, its analysis, and resultant conclusions. Therefore, the 
importance of epistemological integrity, representative credibility, analytic logic and 
interpretive authority was enhanced by using systematic methodology and transparent 
procedures in determining credibility in findings.  For this study, strategies included repeat 
interviewing, member and peer checking, reflexivity, rigorous sampling, and audit trails to 
assist in reporting findings that are credible, (Creswell, 2013; Curtin & Fossey, 2007; 
Patton, 2015) and that transparency in analytical reasoning was maximised.  Additionally, 
two researchers conducted independent analyses and coding of transcripts prior to 
meetings, with a third researcher involved if consensus had not been able to be reached in 
any aspect of this process. 
3.5.1 Peer Checking  
Peer checking is the process whereby a researcher involves a peer who is not involved 
in the research project, or is able to be impartial, to provide academic guidance and 
encourage lateral thinking with regard to methodology, interpretation and analysis of 
data (Denzin & Lincoln, 2011). Involvement of an impartial peer may detect over-
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emphasized and under-emphasized points, vague descriptions, errors in data or biases 
or assumptions made by the researcher. As a novice researcher conducting this 
qualitative research, the engagement of an academic expert was paramount and 
therefore regular meetings with supervisors and other experts in the field was essential 
in enhancing the credibility and trustworthiness of this research. 
3.5.2 Reflexivity 
Reflexivity has been defined as “self- awareness and critical reflection of the ways in 
which the researcher might have influenced the objectives, process and outcomes of 
the research” (Finlay & Ballinger, 2006, p. 262). In ID, the subjective and experiential 
knowledge that the practitioner-researcher brings is actively valued and Thorne (2008) 
acknowledges that reflexivity is a key element in all qualitative inquiry. Situating oneself 
as a researcher within the research role and the research setting is important. Whilst 
“empathic neutrality” (Patton, 2015 p. 46), is sought in qualitative research, awareness 
and exploration of selective perception, personal biases and theoretical predispositions 
was required and needed to be acknowledged prior to, and during interviewing and data 
analysis.   A journal was used by the researcher throughout this study to document 
thoughts, impressions and ideas, particularly during data collection and analysis.  
Additionally, issues such as “power” in the context of interviewing needed to be 
considered.  The researcher, in choosing to be the interviewer, had to acknowledge the 
subsequent power issues that may have occurred but also recognise that existing 
rapport with interviewees may have facilitated more honesty during interviewing.  The 
researcher had known all participants for at least 6-months and therefore rapport 
building was not difficult however the potential issue of power imbalance was 
recognized.   
3.5.3 Member Checking 
Member checking, also known as “participant validation” is a technique used to test the 
validity, or truth, of research findings.  In this technique, emergent findings are returned 
to those who participated in the research to ensure they reflect the meanings intended 
by the participants.  Thorne has advised caution with this process as confirmation from 
participants may lead to false confidence or alternatively, “derail you from good analytic 
interpretations if they do not agree” (Thorne, 2008, pg. 159).  Instead, suggestions are 
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made for repeat interviewing to provide “confirmation, clarification and elaboration of 
any relationships you suspect might exist but have not been articulated”.   
This study did use member checking in a modified way as participants were keen to 
have a summary of what their initial interview produced.  Therefore, participants were 
provided with a summary of thoughts and findings from their initial interview and they 
were encouraged to provide feedback either in written or verbal form. 
3.5.4. Repeat Interviewing 
Thorne (2008) recommends repeat interviewing of participants to clarify evolving 
interpretations.  This enabled the researcher to delve further into concepts and offered 
the opportunity for the participants to articulate ideas or feelings that emerged from the 
first interview.  Despite this, the subsequent interviews did provide ideal opportunities to 
delve deeper into the emotions and feelings of the participant. 
3.6 SUMMARY 
ID is a qualitative research approach that emerged in response to the clinical needs of 
applied health disciplines.  In addition to examining phenomena and generating theory, the 
qualitative findings of an ID study aim to generate findings that potentially contribute to 
clinical practice and guidelines.  Therefore, this methodology was the most appropriate for 
answering the clinical question posed by this researcher.  The findings will contribute to 
lymphoedema research in the context of occupational therapy practice, which may 
improve patient care and inform practice and policy. 
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CHAPTER 4: FINDINGS 
Using purposive and convenience sampling, 11 participants consented to participate 
between the period of January 2015 to November 2016. A total of 20 interviews were 
conducted ranging from 15 minutes to 90 minutes in duration, with the mean time of 42 
minutes.  The sample characteristics and thematic findings are outlined in this chapter.  
4.1 SAMPLE CHARACTERISTICS 
Table 1: Age, Gender, Ethnicity, Marital Status and Employment Comparison (n= 11) 
Characteristic Number Percentage 
Age at interview 
           40-49 (n=3) 
 
           50-59 (n=4) 
 
           60-69 (n=2) 
 
           70-79 (n=2) 
 
Female 
Male 
Female 
Male 
Female 
Male 
Female 
Male 
 
2 
1 
1 
3 
1 
1 
2 
0 
 
18% 
9% 
9% 
28% 
9% 
9% 
18% 
0% 
Race/Ethnicity Caucasian 11 100% 
Marital Status Married/partnered 
Divorced/separated 
Single 
8 
1 
2 
73% 
9% 
18% 
Employment (at time of interview) 
Paid employment  
 
 
Retired 
 
Unemployed 
 
 
Working prior to diagnosis but retired or 
unable to return to work after diagnosis 
 
Female 
Male 
 
Female 
Male 
Female 
Male 
 
Female 
Male 
 
3 
2 
 
3 
0 
0 
1 
 
0 
2 
 
27.5% 
18% 
 
27.5% 
0% 
0% 
9% 
 
0% 
18% 
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The final sample comprised of eleven participants (five men and six women) who were all 
from a Caucasian background and a lived predominantly in an urban environment (ten 
urban, one rural).  Table 1 outlines the characteristics of the study participants including 
the gender distribution across age ranges and employment status.  
Table 2: Participant Treatment Summary 
Treatment Number Percentage 
Operation 
Ilioinguinal n=11 
 
 
 
Female 
Male 
 
6 
5 
 
55% 
45% 
Adjuvant/neo-adjuvant therapy None 8 73% 
 Radiation 1 9% 
 Chemotherapy 1 9% 
 Immunotherapy 1 9% 
RCT allocation 
 
Preventative Treatment Group (PTG) n=5 
 
Control group (CG) n=6 
 
 
 
Female 
Male 
Female 
Male 
 
 
2 
3 
4 
2 
 
 
18% 
28% 
36% 
18% 
Lymphoedema status  
 
No lymphoedema n=5  
 
 
Lymphoedema n=6 
 
 
 
Female (2 PTG + 1 
CG) 
Male (2 PTG only) 
 
Female (3 CG + 1PTG) 
Male (2 CG) 
 
 
 
3 
2 
 
4 
2 
 
 
28% 
18% 
 
36% 
18% 
Melanoma status (at completion of 
interviewing) 
 
No Recurrence n=7 
 
Recurrence n=4 
 
 
 
Female 
Male 
Female 
Male 
 
 
5 
2 
1 
3 
 
 
45% 
18.5% 
9% 
27.5% 
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All participants had undergone the same surgical procedure with the same surgeon.  They 
were seen by the same treating medical and therapy team (except for rotating junior 
doctors) at follow-up appointments that were scheduled every 3-months for 2-years 
following the removal of their surgical drain.  Treatment summary details are listed above, 
in Table 2. 
4.2 THEMATIC FINDINGS 
Once diagnosed, people identified that they were on ‘a strange journey’ (#1) from initial 
reactions of shock and fear through to finding their new normal or facing their mortality. 
They clearly recognised that there was a mix of physical and emotional challenges 
throughout their treatment and monitoring, and that situations and feelings fluctuated. Five 
themes were identified. Reactions to metastatic melanoma- the story of MM diagnosis, 
monitoring, and potential for recurrence, needed to be told before the possibility of 
lymphoedema, including understanding lymphoedema, monitoring, prevention and 
diagnosis, could even be considered. All participants described the impacts on 
occupation, personal relationships and identity and people had a variety of 
experiences with professional relationships.  Finally, participants shared information 
about moving from crisis to coping and reframing their lives.  Many themes overlapped 
and the changing and evolving nature of people’s perceived identity throughout the 
process was particularly noted. 
4.2.1. Reactions to Metastatic Melanoma - “It hits you like a brick”. 
A person’s journey started with the immediate response to MM diagnosis, the surgery and 
post-operative care, followed by the necessity of monitoring, and concerns about 
recurrence. These phases are recognised here with the sub-themes of (a) Initial MM 
diagnosis; (b) Ongoing monitoring for MM into survivorship and (c) Recurrence. 
  
The initial reaction to being diagnosed with MM was a shock to people and something 
they had never anticipated occurring.  The issue of context in this phase was key for all 
people.  Reactions to diagnosis were dependant on factors such as previous health 
status, personal and family health issues and experiences, having dependent children, 
support networks, expectations of others upon the individual and the roles they held as 
52 
 
occupational beings. Initial responses of people who had not experienced previous health 
issues, were characterised by feelings of shock, hopelessness, surprise, uncertainty, 
feeling isolated, apprehension, fear of death, terror and confusion.  One person described 
their response - “I was surprised, shocked! I couldn’t comprehend because I had never 
had anything wrong with me before. Well nothing drastic” (#2).  
People who had experienced previous significant health issues, either personally or of 
those close to them, were more tempered in their responses acknowledging that they had 
been through medical crises before.   
“I’ve had four uncles, no five, die of cancer. And, um, they all got cancer once and 
it killed them.  I’ve had it 5 times now and I’m still going. So yeah, I did think “oh, 
not again” but it’s so long since the last one (cancer diagnosis) … (shrugs 
shoulders) at least they found it when there was still plenty of time to get rid of it. 
Yes, I’m hard to kill” (#3). 
MM is a disease that can affect people of all ages and the reactions, responses and 
decision-making processes varied in accordance with individuals’ occupational roles, 
responsibilities, other co-morbidities and expectations from others. Having dependent 
children, other family with health concerns, managing other’s fears, or expectations to 
take a course of action were identified as factors that weighed heavily on decision making 
for treatment and responses to diagnosis. The feeling of needing to be strong to protect 
others and being too busy to think of negative consequences emerged.  One lady outlined 
her responses to diagnosis and her decision-making processes as follows: 
“I knew I had to control my fear because I knew (my son) wasn’t dealing with it…. He 
cried and said, ‘what am I going to do if something happens to you?’… I had to control 
it and basically function on organising things… That was my way of processing it I 
think.  Don’t think about what’s going to happen, just get this sorted.  If it had just been 
me, I honestly don’t think I would have had the surgery, so I would have had scans 
every 3 months making sure it hadn’t gone further.  That would have been another trial 
but because I knew those three kids depended on me, I had to do something” (# 4). 
Following the acute phase of diagnosis, all people interviewed recognised the importance 
of monitoring for MM recurrence.  This included being followed up every 3-months by the 
surgeon for the first 2-years after diagnosis and then 6-monthly and yearly as time 
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progressed.  Fear of recurrence was present for many and the prospect of upcoming 
appointments left some people feeling “terrified and relieved” (#1) or being on edge for a 
few days after appointments – “So after four or five days if I haven’t heard from him, it’s 
like (enacts a big sigh of relief), there’s nothing there” (#4).   Most however, reported that 
attending follow-up clinic appointments provided a structured avenue for support, 
guidance, understanding and reassurance. “If I hadn’t noticed something or something 
doesn’t look right, I can get it fixed…. I can get in quickly for someone to have a look”. 
(#3). Others recognised the appointments also reminded them that life had been altered.  
“I do feel some security in coming, although it’s a big thing to come because it’s out 
of your normal life.  You almost think “right, I’m back to normal and doing normal 
things” but then that (appointment) letter comes and that means you are NOT back 
to normal.  So even though I value it, it’s a reminder that life is not normal” (#1).   
Some people reported that annoying or negative aspects of monitoring included needing 
to have time off work, travel, waiting times in clinic (public more-so than private), parking 
(availability and cost) and difficulty in locating the clinic.  Generally, however, positive 
responses were highlighted. People felt it kept them accountable and most felt 
reassurance - “I like the knowledge that everyone is keeping an eye on me”. (#3). 
Fears and the apparent need for reassurance appeared to be linked with time since 
surgery.  The goal of reaching 2-years’ disease-free survival was a time when people 
started to “relax” a bit regarding MM.   
“If you can get to that 2 years, you’ve gotten over a big hurdle and life will be 
different after the two years.  I was terrified as I came to that, but I got past that and 
hope built up again that there is life after melanoma” (#1). 
Most people agreed that over time, the frequency of thinking about MM dropped away but 
it didn’t completely disappear.  
“It’s running through my mind that it’s always there…it doesn’t go away totally.  And 
that’s the one thing about melanoma is that it lurks around.  What is it that happens 
that brings it out again?  Is there something that is happening in your life that 
makes it appear?  Is it if your health isn’t good?  So, it’s always there….” (#5). 
54 
 
People reported feeling that MM was different to other cancers and that doctors, family 
and friends and the community at large had less knowledge about it compared with 
cancers like breast cancer.  It was less visible. One gentleman labelled MM an “invisible 
cancer” in his first interview and a “sly little bugger” in his second interview (#6).  This 
echoed the sentiments of others that whilst someone might have MM, they can look and 
feel well for so long and other people would be completely unaware that they are sick.  
Many also felt that MM was not understood and given the attention it deserved. “I just 
want to try to get everybody to understand melanoma the way breast cancer is 
understood.  I would like people to understand the difference.” (#11). 
Recurrence of MM during the follow-up period is a reality for some people with four people 
in this study being diagnosed with progressive disease.  Facing mortality and the 
implications for those who are left behind was important.  Again, context is important here 
and people’s previous perspectives and beliefs regarding death and dying are paramount.  
Emotional issues such as grief, depression, anxiety, fear and anger were reported by two 
people with recurrence. Acknowledging death when people felt well was difficult to 
process and managing the shift in occupational roles and responsibilities posed ongoing 
challenges in the journey towards dying for both the individual and their family.   
“I am 100% about dying on your own terms and lots of people are scared of the 
fact they are going to die.  I mean, it is scary, but I am more scared for other 
people. Because honestly, death is what it is.  You know, if I could change it I 
would, but it is what it is.  Socially, a lot of people have hang-ups about death.  It’s 
completely wrong you know.  It’s just moving on for me…. Because I have already 
thought about it [death], I am not as emotional as they [the family] are about it”. 
(#6).   
It is during this phase that relationships and connections with health professionals will also 
take on different meanings and transparency with regards to individual’s needs, and 
expectations of health professionals and individuals are important.  This will be discussed 
in theme 4 – professional relationships. 
4.2.2. The Possibility of LLL - “From after-thought to harsh reality” 
When the immediate threat of MM had passed, thoughts of lymphoedema emerged.  LLL 
was originally a secondary issue that was considered once recovery from surgery had 
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occurred.  It was a condition that very few people knew about but was then something 
they feared and did not want to get. The impact of the condition was individualised with 
many implications.  This second theme relates to (a) people’s initial knowledge of 
lymphoedema, (b) reactions to monitoring for lymphoedema, (c) experiences of 
preventative strategies and (d) their lived experience of LLL if it occurred.  
Despite all people recalling they had been provided with lymphoedema literature and an 
information session prior to their operation, LLL was initially regarded as a secondary 
issue that people allowed themselves to contemplate only when MM had been surgically 
removed.  
“I took the booklet home and I put it in a cupboard and I did not get that book out 
until after the operation.  It took a lot of energy to then look in it and think, ‘Right, 
now this is another thing I’ve got to cope with’” (#1). 
Most people were unaware of what lymphoedema was, how it was treated or what sort of 
impacts it may have on their lives. “I was blissfully ignorant” (#7).  Many recalled being 
informed of the risks of lymphoedema but acknowledged that conservation of life was the 
primary focus at diagnosis.   
“Well, lymphoedema was the least of my worries then.  If somebody said it might 
be a side effect from the op, well, that was minor for me.  I didn’t care if they said, 
‘we’re going to chop your leg off’…then chop it off if it will help me get through this.  
So, you see lymphoedema wasn’t a major issue for me”. (#1).   
One person (#8) reported “not remembering being told about lymphoedema”, why so 
many lymph nodes had to be removed or even coming out of the operation. Another 
participant who had had axillary nodes removed many years prior did understand 
lymphoedema and suggested that “a lot of people when the doctor is there prattling off all 
this stuff might be worried or nervous…not a lot sinks in” (#3).  Some people reported 
supplementing their educational literature and information sessions with searches on the 
internet.  
“I’m not sure if that was the right thing because Dr Google tends to tell you the 
worst-case scenario…but on the other hand I found support groups and people 
who had been through the same thing to talk to.” (#11).  
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Lymphoedema monitoring was also deemed important with most people seeing it simply 
as an extension of their visit to the specialist.  In addition to the physical measurements 
that were undertaken, people reported that it kept them accountable in terms of their 
exercise, weight management, risk management and overall health. It enabled 
opportunities to answer questions generated from “Dr Google” (#6), and provided them 
with suggestions for ongoing activity, review important educational material and gave 
them confidence knowing that someone else was monitoring them.  “It gives us great 
peace of mind that someone is looking after (the leg) more than just us.  We are trying to 
keep things going as much as we can - but it’s a check-in” (#8).  The therapist role will be 
discussed more in theme 4. 
For those people who had been randomly allocated to the preventative treatment group in 
a concurrent RCT, the experience of wearing compression garments and doing self-
massage daily for 6-months was reportedly positive.  The daily process of wearing 
garments and conducting self-massage was seen as realistic and achievable, with none 
abandoning the regime during that time.  At the time of the interviews, none of the people 
interviewed in the intervention group had developed lymphoedema.   
Opinions varied regarding the component they felt was most beneficial with some 
indicating the thigh length garment and others highlighting massage as being more 
effective. For some, physical factors such as discomfort with the compression bike pants, 
initial feelings of getting used to the tightness, perceived increase of temperature with the 
extra layer of compression garment and having to fit the routine into their day impacted on 
100% compliance.  
“It took a bit of getting used to.  As I told you the first time I came down, I hadn’t 
been doing it to the letter straight up.  But once I got used to it, it wasn’t too bad.  
Wearing the stocking wasn’t a problem.  I never missed a day.   Massage was a 
little different.… but I think that the massage helped more than anything else on 
days I had done a lot of hard work” (#9). 
There appeared to be slight differences between genders regarding the aesthetics of the 
garment, impacts on clothing choice, social interactions or day to day functioning. Males 
tended to be less concerned with aesthetics and “not give a stuff” (#6); “doesn’t bother me 
to look just a little bit different” (#9), or “it hasn’t interfered with anything I’ve done” (#3) 
although those in physical jobs were impacted on occasion. One lady reported she “didn’t 
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wear the body part [bike pant] because they were too hot.  Too much around my waist” 
(#2).  
Despite some reported issues, all people felt that the intervention was effective, with some 
commenting that they missed it and felt naked when the weaning phase commenced. 
Overall, “I think it seemed very effective.  If I was to go through similar surgery again, I 
would definitely do it again.  It wasn’t that inconvenient in the long run” (#9).  Everyone in 
the LLL prevention group reported that wearing a garment in a sub-tropical climate was a 
negative aspect, but one that they managed.   
Typically, the progression and diagnosis of LLL occurs anywhere from 3-15 months’ post-
surgery, with a person having a lifelong risk due to the removal of nodes. Six (54.5%) of 
the eleven people interviewed in this study developed LLL.  The initial diagnosis of LLL 
brought frustration and disappointment, a harsh reality that this chronic condition would be 
with them for life and was a reminder of the journey they had already experienced in 
surviving MM.  
“The lymphoedema has impacted me more.  The melanoma was gut-wrenching 
with all the feelings I went through but that’s over and done with.  Lymphoedema is 
not over and done with and it’s never going to be…” (#4).  
When asked specifically if LLL or MM was worse, people who had not experienced a 
recurrence of MM felt that the LLL was worse than the melanoma.   
“The lymphoedema has had the biggest impact. It’s been a very up and down 
journey. Sometimes you can cope (with lymphoedema) and other times it just 
overwhelms you…completely overwhelms you.  I wasn’t prepared for this.  I hadn’t 
been told enough. I hadn’t read up enough, I hadn’t spoken to anyone who had it.  I 
was not prepared for the restrictions, the pain and even just the clothes restrictions.  
It’s depressing to go out and try to get a pair of shorts and it’s really depressing to 
not be able to get it up your leg.  So, it’s a hell of a roller-coaster.” (#4).   
People who developed LLL identified many physical, psychological, social, and 
occupational issues that impacted negatively on their lives. These issues will be 
discussed in full in theme 3.  
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4.2.3. Impacts on Occupation, Personal Relationships and Identity – “I am not the 
same person” 
As people continued their journey after surgery for MM and lived with the possibility or 
reality of LLL, they reported changes in many areas of their lives.  This theme includes 
experiences of changes in activities of daily living (ADL), paid and unpaid productivity 
roles, and leisure/social interactions; changes in personal relationships and the 
subsequent changes in their sense of identity and sense-of-self.  Contrasting experiences 
existed for individuals, depending on their living situation and not all changes were viewed 
negatively.  It was apparent that the sudden and unplanned introduction of MM into their 
lives impacted their perception of life significantly.  For those who went on to develop LLL, 
the magnitude of changes in day-to-day living were not anticipated and the chronicity of 
the condition became evident. 
The impacts on occupation (basic ADL, work and leisure) were apparent. People reported 
that MM had significant physical impacts in the short-term period following diagnosis due 
to surgery and recovery. However, there were also longer-term impacts, particularly for 
those who developed LLL.  This sub-theme explores the impact that MM and LLL had on 
(i) Basic ADL’s such as grooming, hygiene, dressing, mobility, and sexual activity (ii) 
Work/productivity (home management, carer tasks, educational and vocational activities); 
and (iii) Leisure/social interaction (play, leisure pursuits, social engagement).  This 
included the impact on role functioning and changes in routines or habits.  
MM and LLL had impacts on a person’s ADL.  Physical factors such as surgical wound 
site issues, the drain, and restricted ROM interfered with showering, dressing, mobility, 
transfers, intimacy and socialising for a minimum of 6-8 weeks post-operatively.  “I didn’t 
go out much – that bag!”  The same lady reported how having a surgical drain for 6-weeks 
meant she “couldn’t rush around as quickly and getting showered and dressed became 
more difficult” (#2) whilst another reported that “intimacy was affected” (#6).  Ongoing 
sensory-motor issues from superficial nerve damage and scarring persisted longer term 
and for some never returned to normal but did not pose significant issues for ADL.  In 
situations where a person needed adjunct therapies such as radiation, chemotherapy or 
immunotherapy, physical symptoms such as radiation burns, fatigue, cognitive changes 
and reactions to drugs were reported.  Impacts such as “physical tiredness from the 
chemo” (#7) the “need to sleep a lot because of the immunotherapy….and not 
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remembering things” (#6), and the “ongoing fatigue” (#11) were highlighted by some 
participants. This resulted in decreased activity and engagement at home. 
For those on the preventive program there were minimal impacts on ADL. Factoring in 
time to complete the SLD and put on the garment was noted but not one person 
abandoned the preventative program, perhaps suggesting that it was well tolerated and 
received. 
During this study, six out of eleven people interviewed developed LLL.  Five of these six 
people were in the control group of a larger RCT where no active preventative treatment 
was conducted, and the remaining person was in the preventative treatment group and 
wore compression garments and conducted daily massage for 6-months.  LLL occurred 
between 3-15 months after surgery and the primary ADL areas that were impacted were 
dressing, mobility and transfers.  The implications for self-care were evident with some 
people needing physical assistance to don or doff garments and conduct daily lymphatic 
massage as part of treatment. Mobility and transfers became difficult due to the 
heaviness, tightness and pain that can accompany LLL. “Just getting up and down out of 
a chair is a struggle whereas that never used to be” (#4) or: 
“Physically, my husband and I would walk 25km on a Sunday and I can’t do that 
now.  I physically cannot walk that distance because my leg would just blow up” 
(#5).  
The physical challenges of finding clothes and shoes that would fit their 
lymphoedematous limb were expressed emotionally as distress and frustration, 
particularly by female participants.  Wearing the compression garment also posed 
challenges, physically and emotionally.  
“Its lots of little things like if I don’t wear my garment I have to wear shorts to stop 
my swollen thigh chaffing, which I never had to do...Shoes - shoes do my head in.  
I can’t find shoes to fit! It’s depressing.”  (#4).   
The same person went on to report: 
“I have been struggling to get [the garment] on, especially in the heat.  I have the 
fan boring on me but there have been many mornings when I have been struggling 
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to get it on and I’ve just sat on the bed and howled – I just can’t do this anymore!”  
(#4). 
The subsequent changes required in habitual routines were acknowledged by all who had 
LLL, with the need to allocate extra time for donning/doffing garments or fitting in time for 
massage.  They recognised changes in their daily hygiene routine, or changes in clothing 
or shoe choice that were unavoidable and frustrating.  Over time however, these changes 
were generally accepted, and these new habits formed a basis for optimal management of 
their LLL. 
“My friend does my massage in the morning and evening and puts on my garment, 
because I can’t do it myself. That’s the routine we now have, and we work our life 
around that. It’s impacted on my life, but I’ve learned to cope with it….so I wear it 
(the garment), grin and bear it!”  (#8). 
Participation in work or productive activities was impacted by the diagnosis, surgery and 
other treatments, by the preventive program and by having LLL. All people were impacted 
by the time it took to recover physically from MM surgery, but the degree of impact related 
to the roles they held (paid employment, self-employed, physical labourer, full-time carer, 
retiree), the type of work they did (physical versus sedentary), their support networks 
(family, friends, workplace) and any pre-existing co-morbidities they may have had (heart 
conditions, arthritis). For those in paid employment, this took the form of sick leave or 
unpaid leave for periods averaging 2-3 months.  For those who were home makers, 
carers, or for those roles external to paid work, short-term arrangements were made and 
anticipated, and therefore did not appear to be problematic physically, psychologically or 
financially in the short term.   
“I had tons of sick pay owing….and I love watching movies, so I just kicked back on 
the lounge and watched TV.  I managed really well personally, and I quite enjoyed 
it” (#3). 
Others undergoing radiation, immunotherapy or with pre-existing co-morbidities required 
longer time off paid work with some needing 6 or more months of leave and a graded 
return to work program.  Absence from work or productive roles seemed to be linked with 
increased reports of physical and psychological issues.  For one person receiving 
immunotherapy, return to paid work had not occurred at 9-months and unfortunately, an 
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MM recurrence occurred prior to that anticipated recommencement date. In this example, 
there were financial consequences for not being able to return to work following MM in 
addition to psychological costs for the individual. 
“I was feeling anxious and treatment (immunotherapy) was affecting me.  Hanging 
around home being bored; being on other medication and what it does to your 
brain…so yeah, I ended up at a counsellor/psychologist and that sort of got me 
through. I ended up having to get social security, but they only let me have it when 
I basically emptied my account, so that was a bit of a shock.  It was hard 
financially.  Luckily my partner was working” (#6).   
There were mixed feelings about sharing their MM diagnosis with employers or others 
outside the family.  Some people reported feeling fortunate to have supportive vocational 
environments that actively enabled them to take time off for appointments or programs 
that contributed to their wellness.  
“My work knows, and they do give me time off for appointment. They do change my 
shifts, so I can attend my support groups and attend the cancer council living 
mindfully sessions if I need to…. I am very, very lucky” (#5).   
Transparency regarding their medical diagnosis and the willingness of the employer to be 
flexible and accommodating resulted in mutual respect and feelings of support.  
Conversely, another person spoke of how commencing a new job following the MM 
surgery and lack of familiarity of the people there resulted in the non-disclosure of her 
medical diagnosis. 
 “I never told anybody (outside of my family) about the melanoma and I still haven’t.  
I’ve gotten to the point of sharing and then I’ve backed down.  I haven’t told them 
[at work] because that is almost my private thing that happened before I came to 
that job” (#1).  
Therefore, the decision to hide or disclose a diagnosis of MM in the work environment 
was impacted by the perceived level of support a person had in their paid work 
environment, familiarity and the previous experiences they’d had in that environment.  
62 
 
The degree of impact on work or productivity for those with LLL was dependent on the 
person’s physical role (e.g. active versus sedentary), their attitude and perceived level of 
support and the work environment (ability to modify environment or task).   Those 
returning to full time paid employment reported negative outcomes of increased leg 
swelling and discomfort when being in the one position for too long, particularly sitting with 
flexed knees and hips. This resulted in them changing the physical environment (breaking 
up standing and sitting; alternative work stations such as standing desks), altering 
habitual practices (taking the stairs and not the lift) and even with the importance they 
placed on paid employment or what they did as a job.  One man was very aware of 
changes he had made in his daily work routines. 
 “I can’t leave my leg bent for too long and I’ve started the process to get a 
standing-desk.  I’ve made sure I walk everywhere.  I don’t take the lift.  I walk up 
and down the stairs in the car park.  I use the stairwell rather than take the lift” 
(#10). 
People who cared for others found that living with LLL impacted significantly on their 
ability to fulfil the caring roles they had previously taken for granted.  The physical 
changes such as reduced ROM, strength, flexibility, changes in sensation, increased leg 
size were some of the limitations that negatively impacted on their ability to engage in 
physical pursuits with their family, including play and completing care tasks for small 
children. The same person reported that emotionally, the inability to be involved in 
activities or tasks that had previously been viewed as an integral part of a caring role 
impacted negatively.  “If the kids are playing in the back yard…and I want to make them 
have races to wear them out…I can’t.  [My son] can do it…but I should be doing it” (#4).   
This has impacts for personal relationships which are discussed in an upcoming 
subtheme. 
Despite the negative consequences of MM and LLL, some people identified the 
emergence of new non-paid productivity roles in their lives.  They felt they had become 
educators or ambassadors for a condition or conditions that are poorly understood by the 
community at large. “The more people asked, the more I would tell them what I knew” 
(#6).  One person reported taking on a non-paid ambassador role for the Cancer Council. 
“Raising money…doing collections…to help others who are in difficult situations. I try to 
do things that really make a difference to people” (#5).   
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Additionally, some revised the importance of existing work or productive roles that had 
been in their lives prior to MM or LLL.  
“My perspectives have changed.  I think that I have become better at [my job] 
because that pressure isn’t there anymore.  I walk out at night and instead of 
worrying [about something work related], I see more than that in life” (#1). 
Importantly, many people identified the importance of work or productivity as providing a 
sense of normality or purpose in their lives.   
“The more normal a life you can lead, the more comfortable you get.  When I had 
3-months off work…. I wasn’t living a normal life because I was off work sick. 
Getting back to work brought normality to my life again. That’s what makes me 
normal.  I walk through that door and I am [me] working, not [me] with melanoma or 
lymphoedema” (#5).  
MM had minimal impact on leisure pursuits identified by people in this study, aside from 
the short term physical limitations post-surgery and the heightened awareness of 
remaining sun-smart when out in the sun.  Similarly, there was very little effect on leisure 
for those doing the preventive program, or they worked leisure activities around it. For 
example, some chose not to wear the garment during certain activities and this was   
important to them – “Every Saturday [golf day] I had off” (#10).  
However, the development of LLL had significant negative implications for many people 
participating in leisure activities that required the use of their LL or where they needed to 
sit for long periods with their affected leg flexed. “I can no longer [dance] due to the 
mobility needed.  The heaviness [of the leg] …it’s very fast dancing” (#8).  The loss of this 
activity for this woman was emotional as dancing had been part of her life for more than 
50 years.  Additionally, for her, adaptations needed to be made to enable her to continue 
with her passion for travelling. “We used to go away on long car trips, but I can’t do that 
now.  We do cruises…but we are restricted to around Australia and the South Pacific 
because it’s too long (for the leg) travelling”.  
Conversely, others with LLL took the approach that they refused to let it interfere with their 
leisure pursuits. Some adjusted their garment wearing regime to meet their needs. “I don’t 
wear it [the garment] socially.  If I went out for dinner, I took it off” and, this man was proud 
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that he had become more active in his spare time. “I’ve gone out of my way to do more.  I 
never used to do walks and now I do” (#10). 
For those who had not developed LLL, the commencement of new leisure pursuits was 
common as they recognised the importance of maintaining a healthy weight.  “I have 
started running now which I haven’t done for many years, and I went running with the 
kids.  We did a 5km run yesterday” (#9).  
The impact of conducting preventative strategies by wearing compression garments and 
doing daily self-massage on work, ADL and leisure “took some getting used to, but was 
good” (#9). Whilst feedback from people doing the preventative program was positive, 
there were acknowledgments that wearing a garment and conducting SLD daily for 6-
months (and then weaning out of the program over another month) impacted their ADL 
and work, more than their leisure tasks. People who wore compression garments as a 
way of preventing or minimising LLL did indicate that some work tasks had to be altered, 
and this was dependant on the type of work they did.  For a farmer who conducted 
manual work involving irrigating, getting feet/legs and therefore the garment, wet and 
muddy, changes in his daily schedule needed to be addressed. 
 “If I am shifting irrigation where I am walking in the mud and that sort of thing…. I 
might have done an hour’s work where I thought I might have gotten wet or dirty or 
something…but then come home, have a shower and put the stocking on after 
that” (#9).   
For a lady wearing garments as a preventative measure in the 6-months following 
surgery, consideration of how she would manage household tasks was raised and again, 
context was important.  Females commented more about appropriate clothing choices 
and impacts on function and discomfort when conducting housework – “I just had to be a 
bit careful if there was a bit of water around when mopping or anything…. because [if it 
got wet] I would have had to have gone and got [changed into] the other garment” (#2). 
The impact of the preventative program on leisure pursuits was considered negligible with 
people noting that it “didn’t worry them” (#9) or they simply “took it off” (#10) for particular 
activities and put it back on afterwards. The SLD was not considered a chore and 
reportedly, did not negatively impact on their day-to-day functioning for those in the 
preventative treatment group.  Only one person in the preventative program progressed to 
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LLL, so the responses made by this group may reflect being able to accept the short-term 
duration of garment wear and daily SLD.  If more people in the preventative program 
progressed to LLL, the feedback may have been very different. 
Many ADL, work and leisure activities discussed in this sub-theme were undertaken with 
partners, families, friends or loved ones.  Therefore, the repercussions and potential 
changes in relationships were also noted.  There were positive and negative impacts on 
personal relationships when living with MM and/or LLL. These are discussed in the next 
sub-theme.  
Personal relationships were affected for people.  The diagnosis of MM had repercussions 
beyond the individual to their support networks that included partners, family, friends and 
spiritual relationships.  From diagnosis to survivorship of MM, personal relationships were 
transformed in a multitude of ways.  In some instances, stories of strengthened bonds and 
increased awareness of loved ones were told.  Other stories portrayed lost or forever-
changed friendships.  Relationship status and degree of support networks were relevant.  
People in relationships or with dependent children reported more changes in personal 
relationships. “I felt so reliant on my husband and I’ve never been like that…our 
relationship definitely strengthened” (#1). The same woman recognised that her brush 
with possible death positively changed her relationship with her children. “I think it’s 
deepened my relationship with the children because I always feel that this is time that I 
would never have had with them” and her relationship with god. “I always believed that 
God had a plan and a purpose for me.  It left me questioning my faith, but I came out 
strong”. 
For one man who had recurrence of MM and was facing death, the complexity of 
balancing his end-of-life needs, whilst supporting a family that had begun to grieve his 
loss, was evident.  
“At the moment, they [the family] are pushing back. They’re not too happy but I will 
give them time and let them talk amongst themselves and see how they deal with 
it…. I’d rather get it [death] on the table and deal with it now when you can do all 
the crying” (#6). 
He went on to say, “I don’t want them to see how vulnerable I am or how things really 
are…because it just makes me feel bad…I have other things to do now”. 
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Loss or changes in friendships was also reported. One person described the situation of 
having very close friends who supported her when she was first diagnosed but then 
drifted from her life as her priorities and perspectives of life changed.   
“One of those friends I have made contact with again…and she blamed me which I 
felt was a little unfair…Things will never be the same again, but at least we have 
made contact.  Another [friendship] is a lost cause. She told me that I’d changed, 
and I agree with her.  I have changed.  But I don’t think I’ve changed in a bad way” 
(#5). 
As a direct consequence of MM surgery, the development of LLL was perceived to alter 
personal relationships for individuals and their support networks.  Activities that had 
previously been done with other people and were part of their pre-melanoma lives were 
affected.  Examples included “not being able to walk long distances with my husband 
anymore” (#5); and not being able to “go to the park and run with the kids” (#4).  Indeed, 
the complexities and changing dynamics within relationships were evident during this 
theme.  Just as important however, was the recognition that MM and the potential or 
actual development of LLL for an individual, had implications for their relationship with 
themselves.  This will be discussed in the next sub-theme. 
People reported that their outlook on life and their personal identity was altered 
throughout their journey.  This sub-theme outlines the experiences of changes in people’s 
identity and their altered view of their life after MM and potentially, LLL. Responses in this 
sub-theme were shaped by a person’s previous health and life experiences, ongoing 
physical status, their age, support networks and their current roles in life.  Some people 
found it difficult to determine which condition impacted on their identity more (MM or LLL), 
but some were particularly clear in their distinction. Surviving MM made people 
acknowledge the unpredictability of life, face thoughts of death and explore their own 
priorities.  
“I am NOT the same person I was before MM…my priorities and perspectives and 
every bit of who I am is so different.  I live life for NOW” (#1). 
Concepts of being less selfish, helping others, being mindful of family and friends, living a 
balanced life and creating a legacy that others would remember them by were more 
important following their MM diagnosis.  One woman explained it as follows: 
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“Pre-melanoma days I just lived my life for me and my immediate family. I didn’t do 
much extra to help-out those less fortunate. Since MM I have had added purpose 
and I do things…for other people. I do things that people will remember me by” 
(#5). 
That same person, who consequently developed LLL, acknowledged that LLL had altered 
her body-image and in turn, her sense-of-self as well: 
“Psychologically, your appearance affects you…how you feel.  I miss that I can’t 
wear skinny jeans.  I just got into skinny jeans before MM diagnosis and it felt really 
good.  I keep telling myself that if you can’t love yourself then no one else can, but 
it doesn’t work” (#5). 
Men were less inclined to consider aesthetic issues or carer roles as impacting on their 
identity with one man even reporting that LLL had become part of who he was. “I don’t 
view lymphoedema as lymphoedema, I just sort of see it as part of my whole wellness” 
(#10). 
Conversely however, when facing death, reflection on a man’s role in his family was 
evident.  The importance of leaving a legacy to his family and the role of his identity in 
parenthood was acknowledged. 
“I want them [my children] to learn how to live consciously. I’m not big on wealth, 
owning big houses or flash cars.  For me, the quality of a person is the conscious 
way they live their lives and their choices.  And if they can take that part away 
about me, then I’ll be happy with that” (#6).   
4.2.4 Professional Relationships – “I feel very attached to this team”  
The partnership between an individual diagnosed with MM (with or without subsequent 
LLL) and their health professionals was an important long-term relationship.  For many 
people in this study, the initial diagnosis of MM was suspected and potentially confirmed 
in the community by a general practitioner (GP), dermatologist or skin specialist.  There 
were mixed reactions regarding how this was managed but those who felt dissatisfied with 
previous professional care had stories to tell. One person recounted:  
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“going to the GP for a mark on my foot and basically being told that it shouldn’t be 
anything to worry about.  But a scrape biopsy showed it was melanoma and the GP 
rang and said she was sorry, but she had made a mistake” (#4).    
Another told of appointments with series of doctors and GP’s in another country and then 
Australia where “three or four people told me it’s nothing and then ‘BAM’!’, it is something 
serious!  I’ve lost hope in medical professionals in a way…I don’t think I am going to 100% 
believe them” (#1).  Many reported feeling that MM was not something that was well 
understood “even by the GP’s” (#1).  Therefore, people sometimes brought varying 
perspectives to the new relationships formed with the surgical melanoma team and the 
treating lymphoedema therapists.  
Differences were apparent in dynamics and expectations of these relationships depending 
on the role of the professional and the information needs of the individual.  Physical and 
psychological needs altered throughout the course of diagnosis to extended survival or 
recurrence and palliation.  This theme explores professional relationships from patient 
perspectives and incorporates (a) Team roles and (b) Qualities of good teams. The 
relationships formed were important to patients: 
“I feel very attached to this community of workers.  I really don’t feel I ever walk 
away and feel cut off…. I feel it more because I didn’t have anything out there to 
hold onto, so I only had the team” (#1). 
Team roles and partnerships between specialists and the individual with MM and/or LLL 
were reported by people as being important. Traditional standard care for people following 
surgery for stage III MM of the groin or pelvis would comprise of outpatient appointments 
weekly until drains are removed and then every 4-months for two years initially.  They 
would see the surgeon and a melanoma nurse, with referrals to lymphoedema specialists 
only if it was deemed necessary.  People in this study, were asked to routinely attend an 
additional appointment on their outpatient clinic review days to have formal 
measurements of their legs, complete QoL questionnaires, review compression garments 
(where applicable) and receive ongoing education and training in monitoring, managing or 
minimising LLL.  Due to the dual nature of visits, appointments during the first 2-years for 
the surgeon and the lymphoedema therapists were scheduled every 3-months rather than 
4-months as this is standard practice in the field of lymphoedema management and 
eliminated the need for people to visit the hospital at separate times.   
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It was apparent in all interviews that people recognised that the surgeon and his junior 
doctors, the melanoma nurse and the lymphoedema trained occupational therapist 
worked as a united team but had distinct roles and functions within that team.  As 
discussed already in the theme of team roles, people perceived monitoring at the 
surgeons’ outpatient clinic for melanoma and then moving to the therapy department to 
check lymphoedema, was worthwhile. All roles were important, but differences were noted 
in the purpose of each team visit and the differences in environments where the 
consultations occurred. In the early days of this professional-patient relationship, many 
people reported feeling reliant on the surgeon and the therapist for information or 
guidance regarding their care.  “You guys know what you are doing, and I’ll just be led by 
you regardless of the outcomes. You are the experts” (#7).   
Appointments with the surgeon, the junior doctors and the melanoma nurse were 
considered essential and people attended as scheduled.  The outpatient clinics were 
recognised as providing people the opportunity to ask questions about MM, alleviating 
anxiety of recurrences or in some instances, or being the place where they received 
distressing news if MM had returned.  The importance of these appointments was never 
questioned but comments were made about the busy nature of public outpatient clinics 
and the corresponding waiting times to see the surgeon. “Why do I have to wait for 3 
hours and see him for 5 minutes?” (#8), or “they’re underpaid and overworked” (#7). 
The lymphoedema therapist appointment was viewed as an “extension” (#5) to the follow-
up for MM with the lymphoedema therapists focusing on swelling and the surgical team 
focusing on MM.  Outpatient lymphoedema therapy and monitoring appointments were 
also perceived as less anxiety provoking and less hectic than those with the surgical 
team.  One person reported  
“It’s nice to come to therapy and it’s not ‘clinical’…I can sit and laugh and it’s not 
just ‘right we’re doing this; we’re doing that and now get out’ sort of thing… Also, 
you explain things normally – that makes a huge difference.  It’s not a 5-minute 
consultation of get-in and get-out” (#4).  
Additionally, it provided another opportunity to ask questions that they may not have 
asked their doctor due to time constraints or questions they deemed less important for the 
surgeon to answer. “Having my leg being measured gave us a great sense of 
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security…but it also enabled us to ask more questions that we might not have had a 
chance to ask the doctor…just little questions, but helpful for us” (#1).    
Over time, the fear of MM recurrence and the development of LLL reportedly lessened.  
People who reached the 2-year post-surgery milestone without MM recurrence and were 
then able to have 6-monthly rather than 3-monthly check-ups reported dichotomous 
feelings of relief and trepidation.   
“I was happy and pleased because it was step forward and obviously, the team are 
happy.  But when I left…instead of feeling elated, I felt …insecurity and more onus 
on myself.  Now I have to be looking out for myself…. not so dependent on them 
[the treating team].  So, from feeling quite happy, I felt a little bit unsure of myself 
and there was again, a dilemma, you know – I want to come but I don’t want to 
come” (#1).    
For those people who had developed LLL, the reality that they would need to become 
experts in their self- management whilst continuing with ongoing professional monitoring 
for life was apparent but knowing that they were able to contact the lymphoedema 
therapist provided a sense of relief. “I have really appreciated the fact that I can ring and 
come in and get another garment…. it’s not like ‘Your time with us in finished, just sort it 
out yourself’!” (#4). 
Whilst the times between review appointments for both MM and LLL monitoring or 
treatment increased over time, most people recognised the importance of formal 
appointments in terms of accountability.   
“Check-ups are relatively important. Even though I feel like I am in a good space 
and that we are keeping it [LLL] at bay, it is nice to know that there is an anchor 
there that can say ‘You might have slipped back’.  Once I came and saw you and it 
[LLL] had slipped back and we got it back to where it should have been. I think it is 
more reassuring than important” (#10). 
Variances existed regarding how much and the type of information that was provided and 
were reflective of the individual, their personality and coping styles.  Many recognised the 
importance of health professionals in keeping them accountable in terms of minimising 
71 
 
lymphoedema risk factors by maintaining a healthy weight, being active and continuing 
with garment wear or simple lymphatic drainage.    
“I think basically I wouldn't have been so keen to lose this weight but now I'm a bit 
more motivated to lose the weight. I would have just put it down to middle age 
spread and probably taken a bit more of a relaxed attitude, but when you come to 
[the team] … you probably monitor it a bit more” (#10). 
Indeed, the feedback from people about what they wanted in professional interactions 
was explored and the following subtheme will outline what they want from their team. 
People who have experienced MM reported there were a number of components that 
contributed to good professional relationships.  Trust was the most important component 
identified by participants and it was apparent that trust was multi-faceted and built in 
several ways.  This included (i) specialist knowledge, (ii) consistency of team members 
and (iii) communication, respect and honesty.   
The need for people to feel that their specialists are experts in their field was paramount 
for trust as this provided the first step in building confidence for those facing life 
threatening and life altering conditions such as MM and lymphoedema.  One participant 
reported “I was very lucky to get this doctor because I had heard so many wonderful 
reports about him.  You mention his name and they all know him” (#4). 
People acknowledged that they had trust in the surgeon who performed their operation for 
MM with one participant explaining how he felt when seeing another doctor at a review 
appointment - “When it comes to surgery and MM, I want to know that this new guy, he is 
probably 100% on his game, but I already know that that guy (who operated on me 
originally) is on his game” (#6).  Conversely, another participant reported feeling lack of 
confidence with some junior doctors, stating:  
“Fair enough, they had looked at my notes but when it came to looking at me…I 
just thought that I was glad I was in a better emotional state because [their] 
comments would not have helped me whatsoever” (#1).   She went on to suggest 
“Ensuring doctors have background knowledge so you don’t feel so vulnerable 
when they are asking questions because as the patient you are thinking ‘you have 
no idea’ (#15).  
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Whilst knowledge and skill base were highly valued, feedback from this ID study would 
indicate that men and women undergoing surgery for stage III MM have additional criteria 
they deem important in developing trust in long term partnerships with health care 
professionals. Individuals reported that they felt that “continuity and familiar faces” (#10), 
“having people that know me and my family” (#2), “rapport with the doctors and therapists” 
(#11), were very important in facilitating trust throughout the continuum of care from 
diagnosis to survivorship or recurrence.  The issue of continuity of staff across the teams 
was something that most people raised.  “You get to know them. You build up rapport.  
You don’t have to repeat yourself to other people all the time.  You know, those things 
about familiarity” (#6).  
“I think consistency for building rapport with someone helps to build your confidence if 
they know your history and you can talk to them.  Whether that is true or not…it makes 
me feel more comfortable with the person who is dealing with me throughout the 
journey.  It’s like a partnership” (#10). 
Concerns were occasionally raised about seeing new doctors that hadn’t seen them 
before and comments were made regarding the treating doctor’s personality or 
consultation approach.  
“It seemed as if some of them were taking it very seriously and that they were 
showing concern and that built trust.  Others…were doing what they had been told 
to do and maybe felt ‘this isn’t my area of interest so why should I care, and I am 
not really interested’. But anyway, that comes through as a patient” (#1). 
One man reported seeing a “new doctor who didn’t seem to have much time for me until 
the consultant came into the room.  Once he gave me that impression, I didn’t really trust 
him” (#6).  
Particularly with LLL, where therapeutic interaction is quite personal and includes hands 
on touch for lymphatic drainage and sometimes involves sensitive discussion about 
management of swelling in the genital regions, having continuity in staff and in the 
processes conducted was important.  
“I wouldn’t want someone different each time as I wouldn’t have the confidence.  If I 
had someone different I would wonder whether they were doing what you would do.  
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We did have someone different once….and I lost confidence.  It’s the trust that you 
would do the right thing by me and I will do the right thing by you” (#8). 
Additional qualities that contributed to trust were communication, respectful interaction 
and honesty.  These qualities were also identified as “people skills” (#4), “time to talk” 
(#2), “flexibility around appointments” (#3), “showing concern” (#1), “not making promises” 
(#1) and “having a supportive team that I can contact” (#19). One person recognised the 
importance of honest, direct, yet respectful communication between health professionals 
and the people they treat. Pre-existing relationships and the allocation of time can aid that 
interaction.  She described the importance of “being treated as a person, not a patient.  
Not just another tick on the list that you’ve got to do for the day” (#4).  She went on to 
report that when healthy professional relationships exist: 
“Answering tough questions really opened my eyes and made me realise I had to 
do something [about my weight and depression].  If you can have a laugh and a 
good relationship [with your therapist] than I think you could ask those tough 
questions” (# 4).   
The importance of solid professional relationships, in addition to other support networks, 
was another factor recognised as assisting in coming to terms with diagnoses of MM and 
LLL.  These health professionals were part of an ongoing partnership with individuals and 
had the potential to assist or hinder their journey forward towards returning to a normal 
life.  
4.2.5   From Crisis to Coping and Reframing - “You just have to live with it”  
This theme and subthemes explores how people dealt with the traumatic events of MM 
and sometimes LLL, once they have passed through the initial phases of diagnosis and 
surgery. People discussed (a) self-help and coping strategies and (b) reframing or 
reconceptualising what this meant for their lives. During interviews, it was apparent that 
some hadn’t dealt with the emotional impacts that MM and/or LLL had raised and for 
those people, the progression to “coping” had been slower. One person felt that the depth 
of physical and emotional changes in her life were not able to be captured from quality of 
life questionnaires she had filled in for a separate RCT that required tick box responses to 
closed questions.   
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“They [the questionnaires] were just mundane questions that anybody could 
answer.  To me, it was like an everyday questionnaire that I was answering – for 
everybody, not just me” (#8). 
She went on to comment that “there wasn’t a question [on the QoL questionnaires] that 
asked, ‘Did it stuff up your life?’” (# 2). This lady cried unexpectedly during her first 
interview when asked about the inability to continue an activity she loved due to her LLL. 
She went on to acknowledge “It [crying] was a good thing really as it brought it [the loss] 
to the fore and I had not thought about it.  It must have been down-deep, and I hadn’t 
given it attention” (#1).   Unless the consequences of these conditions were apparent it 
was difficult to move forward.  People who considered that they had returned to “normal 
life” could articulate their self-help and coping strategies.  This helped them to reframe 
their experiences and this will be discussed below. 
In terms of self-help and coping, people noted specific strategies for MM (MM support 
groups, ongoing self-monitoring, seeking family support) and for LLL (conducting 
preventative therapy, maintaining a healthy weight, exercising or contacting lymphoedema 
support groups).  Men and woman commented on self-help and coping activities they 
used including: (i) Education and seeking knowledge (ii) Engaging support from others 
and (iii) Purposeful Activity – physical and cognitive pursuits. Individual preferences were 
evident according to personality type, coping style, their lifestyle and the processes 
involved in reaching (or not reaching) an acceptance of their situation. A precursor to 
undertaking self-help activities or engaging coping strategies was to recognise the impact 
that MM and/or LLL may have had in their lives, acknowledging their own role in 
managing these conditions including the importance of concordance of treatment or 
preventative therapy. “Maybe I didn’t deal with it as much as I should have…I was trying 
to be strong for everybody else.  [LLL] has certainly had a big impact on my life” (#4). 
“Everybody is involved, including myself” (#7) and “realising I needed to lose some 
weight…and recognising it [LLL] was depressing me…really opened my eyes and made 
me realise I had to do something” (#4).   
Formal information received from health professionals was often supplemented with 
information gained from reading, talking to others or going online through websites, 
webinars, chat-rooms or using general search engines.   “I like information so that the 
more information for me, the better…the more info, the better your choices” (#6).  
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Conversely, others chose to avoid the internet or discussions with other people for fear of 
hearing information that was not helpful.  “[People] were just so naïve that they were 
frightened, and they frightened me.  So, little knowledge was good for me” (#1).  This 
same person also used avoidance strategies at various times when feelings such as 
“overthinking, guilt or fear” became overwhelming.   This indicates that knowledge was a 
powerful tool, but one that could be positive or negative depending on an individuals’ 
perspective.    
Whilst it was acknowledged that “the information is there if you want it” (#6) many felt that 
the information on MM was not as accessible as other cancers such as breast cancer or 
that some internet information might not be credible.  Therefore, some actively sought 
support through networks or groups such as the cancer council, MM support groups, or 
lymphoedema support groups.  In addition, others recognised the need to utilise specialist 
skills of psychologists, psychosocial-trained occupational therapists or councillors. 
“Sometimes you just need someone to help you line everything up…someone who is 
standing back from the outside” (#6).  
Other sources of informal support came through religious beliefs.  One lady reported “I 
started to rely on my inner faith and that God would take care of me and that he was my 
source [of support]” (#1).  
Physical activity, whether it was returning to previous exercise pursuits or starting 
something new to focus on general health, exercise was reported to be a positive self-
help and coping activity for most people.  “Exercise for me has been really good.  It’s 
made me feel good and it’s made me stronger and helped fight the lymphoedema and 
certainly helped the heart I think” (#10). Additionally, it was something they could choose 
to be involved in or not, therefore providing self-efficacy: 
“Having a choice to do something helped me…. I wanted to see progress 
so…having my leg measured and seeing that my swimming made a difference 
pushed me on…. something I could manage myself” (#1).  
A diverse range of activities were noted that accommodated various personality types, 
ages and socio-economic backgrounds. Other examples of physical activity that assisted 
coping was walking swimming, running, gym classes, dancing, bike riding, hydrotherapy 
and yoga/pilates. The awareness of maintaining a healthy weight range to minimise the 
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risk of LLL or lessen the burden of existing LLL was also noted as a self-help activity and 
a reason to be physically active.  The impact of having LLL was felt by some with the 
need to find alternatives to previous exercise or activity they had once enjoyed.  “I used to 
walk long distances…but now I can’t…however, we have bought bikes now!” (#5).  
Whilst physical exercise and activity were important to people, being engaged in tasks 
that provided cognitive engagement was also identified. Informal cognitive pursuits such 
as “writing a journal” (#1), “having quiet time for myself” (#4), “reflection through 
conversation and involvement in support groups” (#5) were deemed helpful.  Learned 
skills that had been acquired through professional help or through formal group programs 
such as “mindfulness” (#5), techniques used in cognitive behavioural therapy such as 
“self-talk, replacing negative thoughts with positive thoughts and journaling” (#1) were 
also reported as self-help and coping strategies.   
People expressed and managed their experiences differently and this will be discussed in 
chapter 5. Acknowledging their personality and coping style was important in being able to 
move forward into reframing their life.  “I take things in my stride and I’m pretty resilient.  
I’ve always been like that and I think it has helped me all through my life” (#2). 
Reframing occurred when individuals and their families could reflect on MM and, where 
applicable, their LLL journey.  The evolution of reframing required experiencing emotional 
upheaval prior to finding new meaning or an altered sense of self.  People described an 
evolution of acceptance of MM and/or LLL through to an appreciation of life, and for some, 
the inevitability of facing death.   
The shock diagnosis of stage III MM was not something identified in any of the individuals’ 
life plans.  Most people had never heard of LLL, let alone faced the reality of living with 
life-long swelling of their lower limb.  The impacts were far-reaching.  Acceptance of either 
condition was best described by one person who recognised that life in general isn’t 
smooth.  “Just like life – it never goes smoothly.  It can all just turn to shit one day.  It’s 
how you bounce back that matters” (#6).  
Recognition that “you just have to accept it” (#5), that things could be worse or comparing 
themselves to others in more dire situations were strategies that people used to reframe 
or come to terms with their situation.   
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“I do get grumpy [about the LLL] and say that I wished I didn’t have to put this 
[garment] on.  But then I know I have to and my friend says ‘well, you’ve still got 
your leg!’” (#8). 
Some acknowledged that coming to terms with major health events takes time but being 
able return to what they considered normal life was possible.   
“I remember making the point that I never thought I would get LLL...and then I felt 
ripped off.  I’m over that now.  There is definitely life beyond and I reckon I am 
pretty much back to normal – whatever normal is – I am back there!” (#10). 
The trauma of facing a life-limiting diagnosis and living with the possibility of recurrence 
gave many people altered perspectives on day to day living.  Some acknowledged the 
dichotomy of “missing their old lives [that came up on Facebook memory feeds]” (#5), 
whilst simultaneously appreciating the benefits of their new life. 
“I value life less because of what I have been through, and I value life more 
because of what I’ve been through…. Its life given back and although I did value 
those things beforehand, not like I do now” (#1). 
Everyone conceded that things are different now: “You always think about the ‘what if’s’, 
or the ‘it could be worse’, but also, ‘it could be better’ so you live your life a bit differently I 
suppose” (#4). Identifying that positive outcomes have come from a negative experience -
The silver lining…is that I am probably going to lead a much healthier lifestyle than I 
would have had I not had this happen” (#10) and the impact a potential loss of a loved 
one can have on others were noted. “I think it’s made [my son] appreciate me a lot more.  
It’s made him wake up a little bit more and realise the same thing – live your life!” (#4).   
The threat of death from a diagnosis of stage III MM was recognised by all, but for some, 
news of further recurrence and knowing death was imminent was another emotional 
hurdle to face.  The people in this study who received news of recurrence, did not feel 
unwell when their interviews were conducted as they were in the early stages of 
recurrence.  Their responses were therefore reflective of how they were still functioning 
well and not requiring palliative care input.  One participant spoke of the “journey of death” 
(#6).  He went on to comment  
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“I think that I have known since the initial diagnosis by listening to webinars and 
stuff about MM that the prognosis was never going to be that great.  Even though 
there were little wins along the way, so mentally I was preparing myself for it 
anyway” (#6). 
Mentally preparing for death from the outset of diagnosis or having experienced previous 
serious health conditions impacted on their perceptions of death.   
“Well, it’s there.  I can’t change it.  You just have to live with it…It’s relative to what 
I have been through and I’ve known for such a long time that something more 
could happen” (#3). 
The need to feel that they had planned for death for those would be left behind was also 
important for one person at this stage and gave them purpose.  “I want to know that it’s 
sorted – my will, my [life] insurance, my living world…um everything.  Everything’s sorted, 
I will be happy” (#6).  Identifying that their needs would change as their condition 
deteriorated was touched on, but as they hadn’t started experiencing the impacts at this 
point, they were unable to comment further.  
Reframing was different for everyone. The evolution from crisis to coping or facing death, 
demonstrated both similarities and differences between individuals who shared a common 
initial diagnosis of stage III MM.  No two paths were the same, just as no two people are 
the same. Therefore, reframing was dependant on where they were in their melanoma or 
lymphoedema journey, their life experiences, expectations and their current health status.   
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CHAPTER 5: DISCUSSION 
 
The purpose of this ID qualitative study was to explore the experiences, occupational 
performance impacts and needs of people who are at risk of or have developed LLL 
following surgery for stage III MM of the groin or pelvis.  Discussion will initially focus on 
the findings that support existing literature in MM and LLL diagnosis, monitoring and 
treatment.  It will then discuss new findings, particularly with respect to the prospective 
monitoring of LLL and a proactive preventative program for LLL, led by a lymphoedema 
trained occupational therapist.  This is an area that has not been explored in the literature 
previously. This data was viewed through the lens of an occupational therapist. Therefore, 
the impacts of MM and LLL on occupational performance are outlined, recognising the 
complexity of occupational performance, the gaps in knowledge in this area for MM and 
LLL and the challenges of compiling outcome measures that reflect more than one or two 
components of occupational performance. The impacts on occupational performance 
resulted in perceived identity changes of people in this study and this is discussed in this 
chapter. Finally, the impact of relationships between treating teams and perceived needs 
identified by people with stage III MM, with or without LLL, will be explored.  Limitations of 
the study will be outlined, with implications and recommendations for clinical practice and 
future research proposed. 
 
The rich, descriptive data obtained from the twenty interviews with eleven people who had 
a diagnosis of stage III MM, some being involved in a proactive preventative program for 
LLL and some with subsequent LLL, supports existing evidence that both MM and LLL 
are life-changing diagnoses.  Previous studies have focused on MM or LLL diagnosis and 
experiences separately, except for Gjorup et al. (2017) who assessed HRQoL in a 
quantitative study for people with melanoma with or without resulting lymphoedema. To 
the author’s knowledge, this study represents the first qualitative account specifically 
focused on stage III MM of the LL encompassing both MM and LLL issues.  Additionally, 
this is the only study to include and seek patient perspectives pertaining to proactive 
preventative approaches to LLL throughout the journey. 
It is important to note that whilst data from interviews supported many findings in existing 
literature, which might suggest that the sample of people interviewed were a 
representative sample of people with stage III MM, the individuality of participants’ 
experiences, impacts and needs was evident throughout all aspects of the journey from 
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diagnosis, monitoring, preventative programs and treatment for both MM and LLL. This 
speaks to the importance of treating people as individuals with unique life histories, 
experiences and contexts and reminds health professionals that they must not adopt a 
one-size-fits-all approach. 
5.1 SUPPORT FOR EXISTING LITERATURE ABOUT MM AND LLL 
 
Many of the findings in this study replicate or support existing literature in the fields of MM 
and LLL.  Emotions such as shock, fear, apprehension, hopelessness and confusion were 
reported during the acute phase of diagnosis and surgical intervention for stage III MM 
diagnosis which are consistent with other studies  (Beesley et al., 2017; McLoone et al., 
2013; Tan et al., 2014) and it might be suggested that such responses could be 
anticipated for people with MM undergoing this surgery. The stage and prognosis at 
diagnosis has previously been reported as influencing HRQoL (Hamel et al., 2016; Kelly 
et al., 1995) so consideration of professional support options is important during this time.  
Beyond initial MM diagnosis and surgery, fear of recurrence of MM remained (Tan et al., 
2014), and the positive associations between strong support networks and HRQoL in MM 
noted by Gjorup et al. (2017), Hamel et al. (2016) and Kasparian (2013) were also 
apparent in this study. Not surprisingly, those people experiencing MM recurrence 
required strong supportive care from the treating teams during our study, as recognised 
by Brown and King (2000) and Robinson et al. (2012). 
 
Negative psychosocial impacts were reported during this study, which have also been 
reported in other MM research (Boyle, 2003; Hamama-Raz & Solomon, 2006; Kasparian, 
2013a; Kasparian et al., 2009; Vurnek, Buljan, & Situm, 2007) and across lymphoedema 
literature.  Specifically, changes in social and intimate relationships with lymphoedema 
(Hamilton & Thomas, 2015; Meiklejohn et al., 2013; Winch et al., 2015), factors impacting 
to return to work following cancer (Boyages et al., 2016a; Cooper et al., 2013; Islam et al., 
2014; Moskowitz, Todd, Chen, & Feuerstein, 2014; Shih et al., 2009), financial 
implications (Boyages et al., 2016b; Shih et al., 2009; Stout et al., 2012a), and the 
perceived impact on identity and HRQoL have been reported in wider lymphoedema 
literature (Barlow et al., 2014; Hamilton & Thomas, 2015; Meiklejohn et al., 2013; Winch 
et al., 2015).  Other authors report changes in people’s perspectives of themselves and 
life following cancer (Park, Zlateva, & Blank, 2009; Tan et al., 2014; Trusson, Pilnick, & 
Roy, 2016) as was noted in this study.  
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A fear of developing lymphoedema was reported and the impact of LLL on the lives of 
people in this study demonstrated that physical, psychosocial, and occupational 
performance sequalae are significant.  Various systematic reviews (Cemal et al., 2013; 
Disipio et al., 2013; Leung et al., 2015; Moseley et al., 2007) and studies of ULL and LLL 
from other causes – predominantly BCRL (Binkley et al., 2012; Cariati et al., 2015; 
Devoogdt et al., 2011) and gynaecological related LLL  (Beesley et al., 2007; Dunberger 
et al., 2013; Finnane et al., 2011; Kusters et al., 2015), have reported similar findings.  
Gjorup et al. (2017) reported quantitative impacts of lymphoedema on HRQoL for MM, but 
their results recorded data from people with UL and LLL from people across stages I-III, 
with no recurrence of MM.   Other literature reports on QoL related to LLL in 
gynaecological cancer  (Brown et al., 2013; Finnane et al., 2011; Rowlands et al., 2014) 
and BCRL (de Vries et al., 2009; Montazeri, 2008; Pusic et al., 2013).  Our findings 
support existing research that LLL has a negative effect on QoL.  In this study LLL was 
initially considered an afterthought, however, if it did eventuate, some people articulated 
clearly that they felt it to be more problematic than the original MM diagnosis and that the 
impact on their life was considerable.  Consideration needs to be given to the stages of 
illness these people were experiencing however, as those who reported that LLL burden 
was worse than MM were people who, at the time of interviewing, had not experienced 
MM recurrence.  With the acute threat of life-conserving surgery over, focus shifted from 
the immediate threat of living or dying, to living with a chronic condition that needed to be 
managed for life, whilst still recognising that recurrence of MM was a possibility. Some 
authors have considered this a “response shift” (Yardley & Dibb, 2007) whereby 
psychological adjustment to chronic illness may have occurred when objective changes in 
health status have not. Responses may not have been the same for people who were 
diagnosed with LLL and then found that MM recurrence had also occurred. 
 The physical symptoms of heaviness, tightness, aching pain, swelling and ROM  reported 
by participants are consistent across LLL research (Stolldorf et al., 2016).  Consequently, 
functional impairments due to LLL following MM mirrored those of LLL from other causes 
and included problems such as difficulty donning and doffing garments, getting dressed, 
slowing transfers and mobility due to the increased size and reduced ROM of the leg, 
impacting on travel and work due to the problems with sitting for long periods, and 
impacting on intimacy.   
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5.2 EXTENSION OF EXISTING KNOWLEDGE  
 
Whilst commonalities with existing literature were found, this study reports on new 
information pertaining to people with stage III MM who have undergone inguinal or 
ilioinguinal node dissection and are at risk of LLL.  Research documenting the experience 
of prospective monitoring, or proactive preventative treatment measures for LLL is 
lacking.  Whilst prospective monitoring programs for BCRL (Cheville, 2010; Koelmeyer, 
2016; Stout et al., 2012b; Yang et al., 2016) and gynaecological cancers (Lloyd, 2013) 
cite physical and economic benefits as important outcomes, the evidence-base and 
clinical uptake of such programs for LLL remain limited. This study provides new 
information regarding perceptions of surveillance for LLL as well as feedback regarding a 
proactive LLL prevention program. Exploration into how MM and LLL affect occupational 
performance provides health professionals with a more detailed picture of how these 
conditions can impact daily living.  Additionally, awareness of patient perceptions of their 
personal identity, team roles and professional relationships can help shape effective 
service delivery to this group of people. 
 
5.3 EXPERIENCES OF PROSPECTIVE MONITORING FOR LLL 
All people in this study were receiving proactive monitoring and assessment for LLL 
following ilioinguinal node dissection for stage III MM.  Whilst surveillance models have 
been encouraged by researchers for ULL (Armer et al., 2013; Blaney et al., 2015; 
Koelmeyer, 2016; Stout et al., 2012a) and LLL (Lloyd, 2013),  the traditional mode of 
referral of people to lymphoedema therapists following inguinal or ilioinguinal node 
dissection normally occurs only when their treating surgeon identifies leg swelling at a 
follow-up appointment. The findings indicated that people experienced monitoring for LLL 
as a positive process and felt that formal assessment, education and feedback by a 
trained lymphoedema therapist kept them accountable in terms of looking after their leg, 
weight control, exercise and self-monitoring.  Additionally, it enabled opportunities to ask 
questions that they may not have asked their surgeon, allowed them to dispel any myths 
regarding treatment, provided them with suggestions for ongoing activity, and gave them 
confidence to continue with self-management in the community. Other literature 
recognises the potential positive and negative impacts of monitoring as both an 
assessment tool and intervention technique as it delivers information over time, enables 
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short and longer term goal-setting that is required for changes in learning and behaviour 
and has the potential to maximise self-efficacy (Glasziou, Aronson, & Irwig, 2008).  
Literature in the domains of BCRL and gynaecological LLL (Beesley et al., 2015; 
Dunberger et al., 2013; Finnane et al., 2011) recognise that lymphoedema is a feared 
consequence of cancer treatment. People in this study feared lymphoedema however the 
regularly monitoring by the surgical team as well as lymphoedema trained therapists at 3-
monthly intervals gave them peace of mind.  Monitoring of LLL by separate teams had not 
been documented in the MM literature previously, but this may be reflective of the lack of 
prospective LLL monitoring programs in place. Peak lymphoedema organisations 
recognise that prompt diagnosis and treatment result in improved management of the 
condition (International Lymphoedema Framework, 2006) and that recognition of, and 
access to, expert treatment has been problematic for many people with lymphoedema  
(Lattanzi et al., 2010; Stolldorf et al., 2016; Thomas & Hamilton, 2014).  The previously 
reported experience of difficulty with getting lymphoedema diagnosed, accessing 
appropriate and specialised care and the lack of understanding by professionals and 
community at large was not reported in our study. This may be because people were 
monitored, and early intervention and treatment was available to them as soon as 
concerns arose.  
 
Those people who did not develop LLL during the study reported decreasing concerns 
surrounding LLL development, with increasing time since surgery. For those who did 
develop LLL, the significant impact was fully comprehended only after they had lived with 
the condition for some time. Both Cromwell et al. (2015) and Gjorup et al. (2017), reported 
that coping efficacy and HRQoL improved for all people with MM at 18-months in their 
quantitative studies, regardless of LLL status.  This was not fully congruent with our 
qualitative findings. The interviews in this study were conducted between 6 to 18-months 
following surgery and whilst some people had reportedly come to terms with living with 
LLL, others were still struggling with the impact in all areas of their lives. Therefore, 
conducting the interviews prior to 18-months may not have enabled those with LLL to 
process, accept or deal with the impacts on their lives. An alternate view may be that the 
use of quantitative questionnaires by Cromwell et al. (2015) and Gjorup et al. (2017) may 
not have captured the issues that were relevant for all individuals.  The ability to delve 
further into the meanings of responses in interviews illuminated individual issues for our 
participants and suggests that quantitative questionnaires in isolation may not truly 
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identify what is important for individuals. This was further illustrated by the person who 
stated that she did not feel the two QoL questionnaires completed as part the larger RCT, 
were relevant to her despite being an LLL specific questionnaire and a separate well-
known and validated cancer questionnaire.  
 
This study adds important information to existing evidence in the MM and LLL literature, 
reporting the positive experiences of monitoring for MM and LLL by both the surgical and 
lymphoedema specialists. Feedback from people in the study highlighted the positive 
impacts of monitoring that have been seen in wider literature (Glasziou et al., 2008).  The 
results suggest a possible need for routine support and monitoring of LLL by 
lymphoedema therapists up to 2-years following surgery, with the aim to reduce 
monitoring beyond this time if no LLL is detected.  The routine support can be used to 
educate people about the life-long risk of LLL, understand individual needs and impacts, 
and foster self-efficacy and self-management of their condition.  To the author’s 
knowledge, no study has reported on patient-perceived experiences of prospective 
monitoring of LLL in addition to MM, and certainly not regarding patient experiences of 
LLL prevention programs. 
 
5.4 EXPERIENCES OF LLL PREVENTATIVE STRATEGIES  
This research included five people who had participated in a proactive, preventative 
treatment program aimed at preventing or minimising LLL following surgery for stage III 
MM of the groin and/or pelvis.  Whilst two papers assessing the efficacy of LLL 
preventative treatment programs exist (Sawan et al., 2009; Stuiver et al., 2013), patient 
perceptions of preventative programs have not been explored in the literature. The 
qualitative data obtained during this research suggested that people perceived the wearing 
of compression garments and conducting SLD for 6-months after surgery was both 
sustainable and beneficial. All five of the people involved in the preventative program were 
concordant with the 6-months of preventative treatment with only one of them developing 
LLL during the study period.  Results from the RCT regarding effectiveness of the 
preventative program will be submitted in August 2018. 
People were asked specifically if they felt the preventative program was beneficial and the 
qualitative data collected supported the concept that a preventative treatment was 
acceptable and manageable in their lives. All respondents reported that the process of 
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monitoring contributed to a sense of accountability.  Evidence is lacking in the field of 
consumer perceptions of preventative lymphoedema programs, however self-
management strategies for established lymphoedema are encouraged in conjunction with 
specialist reviews (International Lymphoedema Framework, 2006; Lee et al., 2016), and 
have been found to enhance QoL.  Every participant in this study, regardless of their initial 
motivations for agreeing to participate, conducted the daily preventative strategies for 6-
months.  In line with social cognitive theory (Bandura, 1997), the participants’ belief in 
their ability to have control over events in their life (self-efficacy) was likely to have 
increased due to their ongoing self-management and this plays a key role in coping and 
stress reactions.  This has been reflected in research of self-management for other 
chronic diseases such as chronic obstructive pulmonary disease (Bentsen, Langeland, & 
Holm, 2012) and neurological conditions (Hirsche, Williams, Jones, & Manns, 2011).  
Notably, only one person in the preventative group had developed LLL at the time of 
interview and it is wondered if responses may have been different if people had gone on 
to develop LLL.  
 
People with a diagnosis of stage III MM have undergone many treatments that could be 
deemed invasive and beyond their control. The option of having a therapeutic choice (e.g. 
whether they wore a garment or conducted massage daily for 6-months) may have been 
the first opportunity to control a component of their treatment. Participants spoke of times 
when they chose not to wear their garment to fit within their lifestyle, suggesting that 
having this choice was empowering and perhaps supported ongoing concordance. Many 
theories and existing research emphasise the importance for people managing illness and 
chronic disease to have a sense of control, or perceived self-efficacy (Albrecht, 2013; 
Bandura, 2001; Hoffman, 2013; Jansen et al., 2015; Sherman & Koelmeyer, 2013) and 
empowerment (Aujoulat et al., 2008). Whatever self-management approach is adopted, 
the aim is to empower the person with skills and confidence to better manage their 
condition in partnership with health professionals. The process of learning about and 
understanding the aetiology and management of LLL in a supportive environment before 
the condition developed, may also have contributed to their sense of understanding, 
perceived efficacy to engage in risk management (e.g. minimising cuts/infections, 
monitoring weight) and concordance with the preventive strategies. Supported learning for 
self-management of chronic disease has been acknowledged by researchers (Mirzaei et 
al., 2013) and is reflected in Australian Health policy (NHPAC, 2006). This further 
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supports the benefits of monitoring, education and early intervention programs for people 
at risk of LLL.  
 
5.5 OCCUPATIONAL PERFORMANCE IMPACTS 
 
Recognition that return to work, ADL and QoL are important in the field of MM and LLL is 
increasing (Cromwell et al., 2015; Tan et al., 2014).   Occupational therapists recognise 
that transactional relationships between person, environment and occupation impact on 
occupational performance (Amini et al., 2014; Law et al., 2005) and therefore complexity 
lies in assessing and capturing all areas of occupational performance and the interplay 
they have on a person’s life. Additionally, a change in “occupational identity” (Kielhofner, 
2008) can occur when areas of occupational performance are impacted.  This study 
provides an extension of the current literature by reporting occupational performance 
impacts resulting from MM and LLL, collectively and independently.  Viewed through the 
lens of occupational therapy, this is not a revelation, but the results highlight occupational 
impacts of MM and LLL that may not be fully appreciated by all health professionals and 
do not seem to be captured by all quantitative QoL questionnaires. While reporting 
outcome measures to quantify therapeutic interventions is core business in the health-
care system, therapists working in this field need to ensure they assess and explore 
individual responses to questionnaires and do not rely solely on the changes in numerical 
scores to determine the impact of their interventions.   
 
The findings of this study indicated that surgery for MM resulted in short-term impairments 
of physical function, necessitating use of sick-leave or enlisting support networks to help 
manage paid or non-paid occupational roles (e.g. caring for children).   These short-term 
challenges impacted the ability to perform basic ADL and continue their work roles but 
were expected and not seen as unreasonable.  As occupational therapists, we recognise 
that chronic health conditions can interfere with performance of occupational roles 
(Christiansen et al., 2015).  People in this study underwent the same operation but 
reported very different perspectives during their journey, reflecting the understanding that 
occupational roles affect peoples’ experiences of health conditions. That is, the type of 
occupational role a person held (e.g. a single mother with young children versus a retired 
man with a supportive wife) had implications on the extent of impact on occupational 
performance. Having knowledge of a person’s occupational roles and demands, their 
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support networks and their understanding of expected recovery periods is important as it 
can enable appropriate levels of education, support and skill acquisition to be provided to 
individuals before and after surgery. 
Longer term, the impact of MM on occupational performance was determined by 
survivorship status, whether LLL occurred, changes in perceptions of life and sense of 
identity.  Again, this was not completely new or novel data with some studies highlighting 
specific changes in the discrete areas of work, self-care and ADL (Cromwell et al., 2015; 
Tan et al., 2014) in MM.  However, the rich data collected confirms and illustrates that 
occupational performance is more than a list of what they can or can’t physically do, or the 
level of anxiety they may be experiencing, but rather a transactional concept incorporating 
the whole person, their environment and support networks, and their perceived and actual 
life roles (Christiansen et al., 2015). For people who had undergone surgery for stage III 
MM, the ongoing need to be vigilant with follow-up appointments and self-monitoring, fear 
of cancer recurrence and the shuffling of life priorities contributed to altered perceptions of 
their life roles.  These were not always negative, but required a period of time for 
adjustment and acceptance, in a similar way as people processing loss or grief go through 
various stages (Kubler-Ross & Kessler, 2014).  For those who developed LLL, the 
additional physical and psychosocial burdens were reported in changes in paid and 
unpaid work roles, cessation of previous leisure pursuits and modifications in ADL. 
Disparity between discretionary and non-discretionary areas of occupational performance, 
that is, the things we generally have to do versus the things we want to, may not be 
captured in questionnaires and this has been reported in wider occupational therapy 
literature (Orellano, Colon, & Arbesman, 2012).    
Issues such as fatigue (Albrecht, 2013), work or role functioning issues (de Vries et al., 
2009; Stamataki et al., 2015; Weitman et al., 2017), depression and anxiety have received 
attention in melanoma literature (Kasparian et al., 2009; McLoone et al., 2013) , as have 
financial impacts of MM and LLL (Gjorup et al., 2017; Whiteman et al., 2016). However, 
the changes in habits or routines that were described, and which could manifest in 
emotions such as boredom, anger, agitation and frustration have been less documented.  
These sequelae were more readily described by people in the context of an interview and 
may not be fully captured by the currently adopted questionnaires or standardised tools. 
Therapists might therefore utilise approaches such as activity card sorting, goal checklists 
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or probing interview techniques during therapy to elicit foster discussion and exploration of 
these potential issues. 
There were diverse experiences reported from those who had returned to work regarding 
disclosure of their MM diagnosis as well.  Those who perceived their employer to be 
supportive and empathetic of their need to take leave to attend appointments for MM 
monitoring, expressed their gratitude and appreciation.  Those who were unsure of how 
supportive their employer would be, reported non-disclosure of their MM from their work 
environment and for some, this also extended into withholding details from their friends.  
Some of these factors have been reported in a study considering return to work in which 
groups of people with differing cancer types reported supportive work environments and 
flexible working arrangements as positive factors in return to work (Cooper et al., 2013). 
However, the study did not include people with MM, so caution is required in assuming 
factors for return to work following MM are the same as other cancers.  A Cochrane 
review (2015) reported moderate quality evidence that multidisciplinary team involvement 
incorporating physical, psychological and vocational treatments led to better return to 
work rates in people with cancer however, this  was not specifically MM related (de Boer 
et al., 2015).   
In breast cancer, where arm lymphoedema may be an additional complication, it has been 
found that return to work can be further impacted (Boyages et al., 2016a). Therefore, one 
might postulate that development of LLL also has impacts on return to work and further 
research is recommended.  If perceived support in the work environment is a factor in a 
smoother, and less stressful return to occupational roles, it will continue to be important 
for therapists to be aware of people’s individual circumstances. 
5.6 IDENTITY 
Occupation, occupational  performance and identity are intertwined (Christiansen et al., 
2015).  Keilhofner (2008) would suggest that alterations in occupational performance 
result in occupational identity changes.  Not surprisingly, as time from diagnosis and 
surgery for stage III MM increased, people reported experiencing changes in their identity 
and what was important in their lives. Various researchers in the fields of psychology and 
medicine have looked at responses to MM diagnosis in terms of anxiety, depression 
(Kasparian, 2013b; Kasparian et al., 2009), PTSD (Kelly et al., 1995) and coping (Tan et 
al., 2014) but have stopped short of linking these concepts with changes in identity.  
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People’s perception of identity-change in this study seemed to be dependent on how 
people had reframed or reconceptualised their experiences of either or both conditions 
(MM or LLL) when they were in the extended survival phase following MM.  Theoretically, 
this may reflect “post-traumatic growth” (Hefferon, 2009), whereby over time people were 
able to find some positive meaning from their experiences, accept their new normal, and 
recognise that life continued. Others have studied the concept of “response shifts” in 
people with cancer (Oort, Visser, & Sprangers, 2005) and other chronic conditions 
whereby people’s self-evaluation of their situation changes over time due to changes in 
how they internally perceive their condition (recalibration), how they prioritise factors in 
their life (reprioritisation) and how, in turn, they redefine (reconceptualise) their situation 
(Lix et al., 2016; Nagl & Farin, 2012; Yardley & Dibb, 2007).  Such a shift could be a factor 
to be aware of in LLL, which is a chronic condition, and for those in extended survival 
following MM.  
This concept of perceived identity-change following trauma or ongoing chronic conditions 
is complex, and it is not the aim of this thesis to explore this in depth.  Rather, it was clear 
that people acknowledged being on a “journey” and were re-evaluating their priorities 
following a potentially life-threatening diagnosis.  Literature relating to social-cognitive 
perspectives on coping with cancer (Hoffman, Lent, & Raque-Bogdan, 2013), also reflect 
shifts in perceptions and life-priorities.  An example of this was provided by a person in 
the study when she outlined the changes she had made in her work-life balance after the 
experiences of both MM and LLL diagnosis. Rather than choosing to work longer hours 
for financial gain, she reported she now chooses to be a volunteer for the Cancer Council 
and that her awareness of her own needs during diagnosis and treatment heightened her 
social conscience making her want to support others during cancer.  Responses were 
shaped by many factors such as their previous life experience, ongoing health status, 
support networks and current occupational roles in life, and as such, no two experiences 
were the same. 
5.7 PERCEIVED NEEDS OF PEOPLE WITH MM, WITH OR WITHOUT LLL.      
The needs of people with MM across a number of stages have been studied and reported 
by Kasparian (2013), and specifically for stage III MM (Tan et al., 2014) but this is the only 
study the author is aware of that has focused specifically on people with stage III MM of 
the groin/pelvic nodes. Similarly, the needs of people with lymphoedema have been 
explored in BCRL (Armer et al., 2013; Binkley et al., 2012; Ridner et al., 2016) and LLL 
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due to gynaecological surgery (Beesley et al., 2008; Carter, Penson, Barakat, & Wenzel, 
2012; Finnane et al., 2011).  Cromwell et al (2015) explored MM and LLL together by 
reporting on lymphoedema coping efficacy, adaptation and adjustment to lymphoedema 
diagnosis and the impact of lymphoedema.  Their study included people with stage I-III 
melanoma, UL and LL and included SLNB and TLND surgeries but did not highlight 
participant needs.  Therefore, to the authors knowledge, this qualitative thesis is the first to 
explore the perceived needs of people with stage III MM of the groin/pelvis, who are at 
high risk of LLL and the needs of people undergoing follow-up monitoring and treatment. 
The results of this qualitative study reflected many of the needs already documented by 
previous research but also highlighted the importance people placed on relationships with 
health professionals and information regarding their care.  These needs included: 
 
(1) forming strong, trusting, healthy relationships with a consistent team of health 
professionals who not only monitored for MM recurrence and LLL, but who 
demonstrated specialist knowledge, communicated honestly and respectfully, 
showed empathy and concern were able to address psychological, physical and 
emotional issues as they became apparent; 
 
(2) Access to information regarding MM and LLL, but tailoring this to the individual 
depending on how much they could cope with at various times and;  
 
(3) Timely access to treatment and specialist resources in the event of developing 
recurrent MM or LLL. 
 
Communication in cancer care is understandably, a complex issue. Recognition that 
satisfaction with care, including needs that are met, are important aspects of cancer 
survivorship and concordance have been highlighted in recent years.  Australian health 
care policy recognises consumer or person-centred care is required to maximise quality of 
care and consumer satisfaction (ACSQHC, 2011) . No clear definition exists, but core 
themes have been identified including participation and involvement of the person 
receiving care, the importance of the relationship between that person and healthcare 
professional, and the context of where and how care is delivered (Kitson, Marshall, 
Bassett, & Zeitz, 2012).  Despite this, evidence informs us that across mixed cancer 
studies, high levels of unmet needs have been reported in psychologic domains, health-
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system and health-information domains, and physical and daily domains (Sanson-Fisher et 
al., 2000) of people with cancer.  
 
Existing MM literature reports unmet needs across various melanoma stages (Beesley et 
al., 2017; Beesley et al., 2014; Jones et al., 2015; Kasparian, 2013b; Molassiotis et al., 
2014; Palesh et al., 2014; Stamataki et al., 2015). People want accessible expert medical 
attention, client-centred care, and prefer to see the same specialist (McCloone et al 2013). 
Information and support needs are highlighted, as are the challenges of managing anxiety, 
depression and fear of recurrence in MM.   Results from our study support existing MM 
research suggesting that these issues are important to people with stage III MM.  The fear 
of developing LLL also exists but remains a secondary concern until the surgical 
intervention for stage III MM is complete. New research findings emerging from this study 
outline how participants perceived the roles within the multidisciplinary team (MDT). The 
experience of proactive monitoring for LLL that was undertaken by the lymphoedema 
trained occupational therapists has not been investigated before. Throughout this study, 
participants perceived the occupational therapy appointments as being less rushed and 
less stressful than the surgical review. This therapy appointment that followed the surgical 
outpatient appointment reportedly provided opportunities for ongoing education, 
clarification of information, assessment and management of psychosocial and physical 
issues, whilst also fostering accountability in risk reduction practices such as maintaining a 
healthy body weight, continuity with exercise or activity and treatment regimes. 
Additionally, participants felt it allowed them time to debrief, raise any concerns or issues 
and seek reassurance about their condition.  Integrated services for cancer survivors have 
been recognised in cancer literature (Recklitis & Syrjala, 2017)  and in melanoma care, 
and recommendations around psychological support are documented (ACN, 2008) but not 
all clinics are resourced adequately to deliver these recommendations.  Some 
lymphoedema studies have reported frustration with accessing lymphoedema services in a 
timely manner (Barlow et al., 2014; Watts & Davies, 2016).  This was not raised as a 
concern by any people in this study as prospective monitoring meant that early diagnosis 
and access to treatment occurred as soon as LLL was detected. 
 
The importance of strong relationships with health professionals in MM has been 
documented previously (Stamataki et al., 2015) and this study reiterates the need for 
people receiving cancer treatment to “feel known” (Thorne et al., 2005) and have positive 
communications and interactions with staff (Stajduhar, Thorne, McGuinness, & Kim‐Sing, 
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2010).  People in this study reported diverse needs in terms of what they felt they needed 
and wanted to know at various time-points but without exception, trust and transparency 
between the health professional and the patient was deemed essential.  The links between 
positive communication, psychological status and neuro-immunity continue to be debated  
(Gibertini, 1992; Kasparian, 2013b) but positive experiences between patient and health 
professional may bolster self-efficacy, concordance with follow-up and improved self-
management.  
 
5.8 CLINICAL IMPLICATIONS AND FUTURE RESEARCH 
 
People who have undergone surgery for stage III MM and are at high risk for LLL reported 
many factors that impacted on their experiences of care, their needs and occupational 
performance.   Commonalities and differences were noted, and the unique needs of each 
person need to be acknowledged, considered and addressed by health professionals 
throughout monitoring and follow-up stages for MM and LLL. The results from this study 
confirm that adjustment following MM is a complex, long-term process requiring support 
from multiple sources.  The risk, or development, of LLL is an additional concern for 
people once surgery is complete and prospective monitoring for LLL is well-received by 
those having undergone surgery. Proactive, preventative programs for LLL are well 
tolerated and viewed as beneficial by people with no reports of perceived burden.  
Occupational performance and occupational roles following stage III MM and LLL are 
affected and the implications for identity need to be considered during care.  The role of 
health professionals in partnering with people during their MM and LLL journey has the 
potential to assist people in managing and fostering positive health outcomes.  Supporting 
people throughout the continuum of care, assisting them to re-frame and perhaps modify 
aspects of their life, and supporting the shift in occupational roles and responsibilities, 
suggests that occupational therapists are well-placed in the treatment team for people with 
stage III MM.  
 
Clinical implication 1: MM is a marathon, not a sprint - and it needs a support crew. 
This study clearly demonstrated that there is a long adjustment period following diagnosis 
and surgery for MM, with many factors impacting how people coped and perceived their 
situation. People feel MM is not understood by the community and that the profile of MM is 
not as high as cancers such as breast cancer.  They live with a fear of recurrence and 
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reaching 2-years disease free survival was their first goal. Whilst they recognise the 
importance of 3-4 monthly follow-up by the surgical team in that first two years, it reminds 
them that “life is no longer normal”.  During this time of adjustment with life-threatening 
illness, changes and stresses in their lives, their perceived identity is challenged.  They 
require support networks in the form of family, friends and professionals as each group 
can provide different sources of physical, psychological and social support. 
Throughout the journey of adjustment with MM, and regardless of whether this could be 
considered PTSD (Kelly et al., 1995) post-traumatic growth (Hefferon, 2009), response 
shift (Yardley & Dibb, 2007), or biographical disruption (Bury, 1992; Hubbard & Forbat, 
2012; Trusson et al., 2016), health professionals must play an integral role through 
education to assist in understanding the condition, providing realistic expectations of post-
surgical care and restrictions and gaining an understanding of the recovery process 
ahead. Understanding, assessing and monitoring the potential physical, social, emotional 
and psychological fluctuations associated with MM diagnosis through to survival is 
important to educate, reassure and provide appropriate support throughout the continuum 
of care for people with stage III MM.   
 
Clinical implication 2: Lymphoedema monitoring and preventative programs are 
considered beneficial by people – Knowledge, empowerment and self-efficacy! 
 
LLL was initially an afterthought but monitoring for LLL was considered important by 
participants in this study. In addition, those participating in a proactive preventative 
program of wearing compression garments and conducting SLD for 6-months reported this 
to be both achievable and worthwhile. Prospective surveillance should be considered in 
models of care for people with stage III MM who are at risk of LLL.  This would provide 
opportunities for additional support through education about the condition, reinforce risk-
reduction strategies, provide opportunities to confirm or dispel myths regarding LLL, and 
provide motivation and self-efficacy needed for behaviour change.  These interactions in 
addition to formal outcome measurement can result in people feeling empowered as they 
perceive a greater sense of control or mastery, self-efficacy and competence to manage 
the condition should it arise.  Additionally, if LLL does occur, people have access to 
specialist care, without the stress of delays in diagnosis or treatment.   
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Whilst further research is required to ascertain the efficacy of proactive, preventative 
programs, feedback from this study indicates that involvement by the lymphoedema 
trained occupational therapist from the beginning of a person’s journey was well received. 
Advocating for such input in models of care may provide greater support and improve 
physical, psychological and financial outcomes for people with stage III MM who are at risk 
for LLL. 
 
Clinical Implication 3:  MM and LLL impact on occupational performance and 
identity -Ticks on a questionnaire are simply the tip of the occupational 
performance iceberg. 
 
This study demonstrates that MM and LLL impact on occupational performance, 
individually and collectively, which can result in identity changes (Charmaz, 1995; 
Christiansen, 1999; Kielhofner, 2009; Park et al., 2009) and changes in personal 
relationships. The experience of engagement in occupation is unique for each person, and 
therefore assessing, understanding and respecting each persons’ occupational roles, 
relationships, values and expectations is paramount in helping to an individual navigate 
the complex journey through MM and, potentially, LLL.  Whilst formal monitoring and 
assessment for LLL is important, the assessment and ongoing monitoring of functional 
status, psychological adjustment, coping, stress management and engagement is required 
and should be routinely included in follow-up. Therapists may need to supplement QoL 
questionnaires with in-depth questioning to determine any underlying concerns or goals for 
each patient and the use of tools such as activity cards, journaling, therapeutic use of self, 
or as one patient suggested in this study – “Just ask me what I need today!”  Supporting 
people throughout their change in occupational roles and responsibilities is required in all 
stages of the MM and LLL journey in order to come to terms with adjustment and foster 
self-efficacy and empower people to take control of their self-management. 
 
Clinical Implication 4: Collaborative patient and health professional partnerships are 
essential – “Delve deeper, build rapport, know the person and ask the tough 
questions” 
 
The importance of strong, long-term relationships with health professionals were identified 
by people with trust perceived as the most important element of good professional 
relationships.  People reported that this was built on specialist knowledge, consistency of 
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team members and respectful, honest communication.  Therefore, the importance of 
“knowing the patient” (Thorne, 2005), acknowledging that everyone had individual needs, 
showing concern and empathy, giving people time and checking on their individual needs 
at each appointment was important to people.  A suggestion by one participant captured 
this succinctly by suggesting health professionals ask the question “What do you need 
from us today”. With the increased use of QoL questionnaires measuring outcomes, the 
importance of seeking clarification of peoples’ responses is important and should not be 
forgotten.  Without doubt, QoL questionnaires can be helpful but should be supplemented 
with questioning of the individual to ascertain the pertinent issues for them.  Therefore, 
individually tailored therapy and effective communications will need to remain core 
business, as the relationship between health professionals and the person they treat is 
required for optimal clinical outcomes. 
 
Clinical Implication 5: People require support to reframe their “new normal” 
throughout the disease process, including dying – “Assisting transformation 
through trauma”. 
 
Assisting people to access support services, teach coping techniques and stress 
management techniques such as mindfulness or CBT can be important factors in provision 
of care.   Providing advice on functional activity and exercise for their personal 
circumstances and engaging other relevant health professionals to assist with coping is 
also important in maximising a person’s health and well-being in MM and LLL.   
 
5.9 STRENGTHS AND LIMITATIONS 
 
This study has added to the literature by focussing specifically on people with stage III MM 
who had undergone ilioinguinal node dissection for stage III MM.  All people had similar 
operations, follow-up and were therefore all at risk of LLL.  By focusing only on this group 
of people, it would be anticipated that exploration into their experiences, occupational 
performance issues and needs would highlight issues that would be relevant to this 
specific group.  Secondly, the qualitative, ID methodology of this study utilised in-depth 
interviewing and enabled us to investigate and interpret the complex phenomena of MM, 
LLL and impacts of monitoring, proactive preventative approaches. Having participants 
conduct member checks, multiple coders and ongoing constant, comparative analysis, as 
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well as having feedback from specialists in the field assisted in maximising rigor and 
credibility of the data (Creswell, 2013; Denzin & Lincoln, 2011).  
 
Despite the strengths listed above, this study is not without limitations. Whilst data were 
from men and women of variable ages and backgrounds, the group all identified as 
Caucasian and therefore, cultural differences may not be reflected in these results.  
Additionally, most participants lived in urban centres so the needs and experiences of 
those in rural settings may not have been evident. The treating therapist was also the 
researcher which may have had an influence on the information people were willing to 
divulge during interviewing, as well as how that information was perceived.   Alternatively, 
there may have been potential benefits of the researcher also being the interviewer, with 
improved rapport and trust in divulging information during interviewing, as well as a greater 
awareness of their lives, challenges and support networks throughout their treatments.  
 
All participants underwent surgery with the one surgeon and follow-up was conducted by 
that same surgeon and lymphoedema specialist, therefore all participants received a 
similar treatment experience which could be construed as both a strength and limitation of 
the study.  That is, not all experiences of different types of surgeries or professional 
relationships may have been represented.     
 
5.10 CONCLUSION 
 
This study aimed to explore the experiences, occupational performance impacts and 
needs of people who are at risk of, or have developed LLL following surgery for stage III 
MM.  Firstly, this study supported other research findings in documenting that diagnosis 
and subsequent treatment for stage III MM and LLL are significant events in people’s lives.  
Some commonalities were reported in experiences and needs across MM and LLL 
conditions.  This group of people ideally wanted continuity of care from experts in the field, 
who were able to provide accessible, high-quality follow-up and information.  The feeling of 
being known by their treating team promoted trust and bolstered confidence in their care. 
What this study has contributed however, is that occupational performance impacts exist 
across multiple areas of living, including productivity, self-care and leisure.  Therefore, 
assessment, recognition and treatment of each person’s unique situation is required to 
facilitate optimal return to physical and psychological wellness.  Whilst some 
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commonalities exist, each story is unique, and the needs of individuals should be 
addressed. 
 
This is the first study that we are aware of that has explored occupational performance 
issues and has sought feedback from people regarding prospective monitoring for LLL.  
Additionally, some participants were involved in a proactive, preventative lymphoedema 
program and feedback indicates that such programs do not add burden to their lives and 
are perceived as beneficial. Quantitative outcomes of the preventative program are not 
within the scope of this thesis and therefore, caution is required in recommending the 
adoption of such programs until further evidence is published to support or refute their 
efficacy.     
Occupational therapists are specialists in supporting people to return to productive, 
satisfying and independent lives following physical, psychosocial and emotional trauma.  
Additionally, they have professional skills that can assist with managing stress, coping 
with altered lifestyles or facing death.  Stage III MM and LLL can impact many of these 
areas of living and therefore, occupational therapists would be well placed in the multi-
disciplinary team to attend to the needs of this group.  Whilst further research is 
recommended to determine the outcomes of proactive, preventative treatment 
approaches to minimise LLL in this group, the perceived benefits of such a process is 
reportedly positive and empowering to those people who have undergone ilioinguinal 
node surgery. 
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Appendix C – Interview Questions 
 
Lymphoedema Prevention Following Inguinal or Ilioinguinal Node Dissection for 
Metastatic Melanoma – Understanding people’s experiences of lymphoedema 
prevention 
 
 
Introduction: 
 
 
Please answer the questions in your own words and know that you are under no obligation to answer any questions 
that you might not feel comfortable answering.  Participation in this interview is voluntary and you may cease the 
interview at any time.  You will be provided with a transcript  following the interview to confirm it correctly represents 
what was discussed.  You will also be given an opportunity to add further comments 
 
Questions: 
 
1.  Tell me what it was like when you were told you had metastatic melanoma and had to undergo an operation? 
 
2. What was your understanding of lymphoedema (and your risk of lymphoedema) when you first started this study? 
 
3. Tell me about your experiences of wearing the garments and doing the massage on a daily basis? [Intervention] OR Tell me 
about your experience of being closely monitored every 3 months [Control] 
 
4. How did this impact on your life?  
 
5. From your perspective, what do you think about compression and massage as a preventative treatment [Intervention] OR From 
your perspective, what do you think about the process of being monitored for detection of any early lymphoedema [Control]?  
 
6. What was your experience with the health professionals during the process? 
 
7. Do you have anything else to add about anything we have talked about today? 
 
 
Please note that these questions are the guiding questions for the interviews.  Recursive questioning will be used when 
responding to participants (eg “tell me what that was like….) to further uncover participant’s experiences as required. 
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